<SEC-DOCUMENT>0001193125-23-016260.txt : 20230126
<SEC-HEADER>0001193125-23-016260.hdr.sgml : 20230126
<ACCEPTANCE-DATETIME>20230126162111
ACCESSION NUMBER:		0001193125-23-016260
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20230124
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230126
DATE AS OF CHANGE:		20230126

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KOPIN CORP
		CENTRAL INDEX KEY:			0000771266
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		IRS NUMBER:				042833935
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1225

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19882
		FILM NUMBER:		23558001

	BUSINESS ADDRESS:	
		STREET 1:		125 NORTH DRIVE
		CITY:			WESTBOROUGH
		STATE:			MA
		ZIP:			01581
		BUSINESS PHONE:		508-870-5959

	MAIL ADDRESS:	
		STREET 1:		125 NORTH DRIVE
		CITY:			WESTBOROUGH
		STATE:			MA
		ZIP:			01581
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d432826d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:kopn="http://kopin.com/20230124" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-01-24_to_2023-01-24">KOPIN CORP</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_SecurityExchangeName" name="dei:SecurityExchangeName" contextRef="duration_2023-01-24_to_2023-01-24">NASDAQ</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-01-24_to_2023-01-24">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-01-24_to_2023-01-24">0000771266</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="kopn-20230124.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-01-24_to_2023-01-24"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-24</xbrli:startDate> <xbrli:endDate>2023-01-24</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, DC 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-01-24_to_2023-01-24">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-01-24_to_2023-01-24" format="ixt:datemonthdayyearen">January&#160;24, 2023</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">KOPIN CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-01-24_to_2023-01-24" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-01-24_to_2023-01-24">000-19882</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-01-24_to_2023-01-24">04-2833935</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-01-24_to_2023-01-24">125 North Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-01-24_to_2023-01-24">Westborough</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-01-24_to_2023-01-24">MA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-01-24_to_2023-01-24">01581</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-01-24_to_2023-01-24">(508)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-01-24_to_2023-01-24">870-5959</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see<span style="font-style:italic"></span>&#160;General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-01-24_to_2023-01-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-01-24_to_2023-01-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-01-24_to_2023-01-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-01-24_to_2023-01-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-01-24_to_2023-01-24">Common Stock, par value $0.01</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-01-24_to_2023-01-24">KOPN</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <span style=" -sec-ix-hidden:Hidden_dei_SecurityExchangeName">Nasdaq Capital Market</span> </td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-01-24_to_2023-01-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On January&#160;24, 2023, Kopin Corporation (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Stifel, Nicolaus&#160;&amp; Company, Incorporated, as representative of the several underwriters listed therein (the &#8220;Underwriters&#8221;), relating to the issuance and sale in an underwritten public offering by the Company of 14,000,000 shares of its common stock, par value $0.01 per share (the &#8220;Shares&#8221;) and <span style="white-space:nowrap">pre-funded</span> warrants to purchase up to 6,000,000 shares of its common stock (the <span style="white-space:nowrap">&#8220;Pre-Funded</span> Warrants&#8221;). The offering is being made pursuant to the Company&#8217;s shelf registration statement on Form <span style="white-space:nowrap">S-3</span> (File <span style="white-space:nowrap">No.&#160;333-253933),</span> which was declared effective by the SEC on April&#160;27, 2022, and a related prospectus supplement. Under the terms of the Underwriting Agreement, the Company has granted the Underwriters an option, exercisable for 30 days, to purchase up to an additional 3,000,000 shares of its common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The <span style="white-space:nowrap">Pre-Funded</span> Warrants are exercisable at any time after the date of issuance. A holder of <span style="white-space:nowrap">Pre-Funded</span> Warrants may not exercise the warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of the Company&#8217;s common stock outstanding immediately after giving effect to such exercise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The net proceeds to the Company from the Offering are estimated to be approximately $18.4&#160;million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, assuming no exercise by the Underwriters of the option to purchase additional shares of common stock. The transactions contemplated by the Underwriting Agreement are expected to close on January&#160;27, 2023, subject to the satisfaction of customary closing conditions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, and other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures exchanged between the parties in connection with the execution of the Underwriting Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As part of the Underwriting Agreement, subject to certain exceptions, certain of the Company&#8217;s officers and directors agreed not to sell or otherwise dispose of any of the Company&#8217;s common stock held by them for a period ending 90 days after the date of the Underwriting Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Underwriting Agreement. A copy of the Underwriting Agreement is filed with this Current Report on Form <span style="white-space:nowrap">8-K</span> as Exhibit 1.1 and is incorporated herein by reference. The form of <span style="white-space:nowrap">Pre-Funded</span> Warrant is filed as Exhibit 4.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and the foregoing description of the terms of the <span style="white-space:nowrap">Pre-Funded</span> Warrants is qualified in its entirety by reference to such exhibit. A copy of the opinion of Morgan, Lewis&#160;&amp; Bockius LLP, relating to the legality of the issuance and sale of the Shares and <span style="white-space:nowrap">Pre-Funded</span> Warrants in the offering is filed with this Current Report on Form <span style="white-space:nowrap">8-K</span> report as Exhibit 5.1. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> shall not constitute an offer to sell or the solicitation of an offer to buy shares of Common Stock, nor shall there be any offer, solicitation, or sale of the Company&#8217;s securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">See the Exhibit Index below, which is incorporated by reference herein. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXHIBIT INDEX </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d432826dex11.htm">Underwriting Agreement, dated January&#160;24, 2023, by and between Kopin Corporation and Stifel, Nicolaus&#160;&amp; Company, Incorporated, as representative of the underwriters named therein </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d432826dex41.htm">Form of <span style="white-space:nowrap">Pre-Funded</span> Warrant </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d432826dex51.htm">Opinion of Morgan, Lewis&#160;&amp; Bockius LLP </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d432826dex51.htm">Consent of Morgan, Lewis&#160;&amp; Bockius LLP (included in Exhibit 5.1) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d432826dex991.htm">Press Release dated January&#160;24, 2023 announcing the commencement of the offering </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d432826dex992.htm">Press Release dated January&#160;25, 2023 announcing the pricing of the offering </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:47%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:47%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">KOPIN CORPORATION</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Dated: January&#160;26, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Richard A. Sneider</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Richard A. Sneider</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Treasurer and Chief Financial Officer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">(Principal Financial and Accounting Officer)</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d432826dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14,000,000 Shares </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants to Purchase Up to 6,000,000 Shares </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">KOPIN CORPORATION </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Common Stock </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">($0.01 Par Value)
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>UNDERWRITING AGREEMENT </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">January&nbsp;24, 2023 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stifel, Nicolaus&nbsp;&amp;
Company, Incorporated </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As Representative of the Several Underwriters </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">787 Seventh Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kopin Corporation, a Delaware corporation
(the &#147;<B><I>Company</I></B>&#148;), proposes to issue and sell to the several underwriters (collectively, the &#147;<B><I>Underwriters</I></B>&#148;) named in <U>Schedule I</U> to this agreement (this &#147;<B><I>Agreement</I></B>&#148;) for
whom you are acting as representative (the &#147;<B><I>Representative</I></B>&#148;), an aggregate of 14,000,000 shares (the &#147;<B><I>Firm Shares</I></B>&#148;) of common stock, par value $0.01 per share (the &#147;<B><I>Common
Stock</I></B>&#148;), of the Company and <FONT STYLE="white-space:nowrap">pre-funded</FONT> warrants (the &#147;<B><I>Warrants</I></B>&#148;) to purchase up to an aggregate of 6,000,000 shares of Common Stock in the form attached here to as
<U>Exhibit A</U>. The Company also proposes to sell to the several Underwriters, at the option of the Underwriters, up to an additional 3,000,000 shares of Common Stock (the &#147;<B><I>Option Shares</I></B>&#148;). The Firm Shares and the Option
Shares are hereinafter referred to collectively as the &#147;<B><I>Shares</I></B><I>.</I>&#148; The Shares and the Warrants are herein referred to as the &#147;<B><I>Securities</I></B>.&#148; The shares of Common Stock issuable upon exercise of the
Warrants are herein referred to as the &#147;<B><I>Warrant Shares</I></B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. </B>The Company represents and warrants to, and agrees with, each
of the Underwriters that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(a) </B>The Company has prepared and filed with the Securities and Exchange Commission (the
&#147;<B><I>Commission</I></B>&#148;) a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-253933),</FONT> and such amendments to such registration statement as may
have been required to the date of this Agreement, under the Securities Act of 1933, as amended (the &#147;<B><I>Securities Act</I></B>&#148;), and the rules and regulations (the &#147;<B><I>Rules and Regulations</I></B>&#148;) of the Commission
thereunder. Such registration statement, at any given time, including any amendments thereto at such time, the exhibits and any schedules thereto at such time, the documents incorporated by reference therein pursuant to Item&nbsp;12 of Form <FONT
STYLE="white-space:nowrap">S-3</FONT> under the Securities Act at such time and the documents and information otherwise deemed to be a part thereof or included therein by Rule 430B under the Securities Act (the &#147;<B><I>Rule 430B
Information</I></B>&#148;) or otherwise pursuant to the Rules and Regulations at such time, is herein called the &#147;<B><I>Registration Statement</I></B>.&#148; The Registration Statement at the time it originally became effective is herein called
the &#147;<B><I>Initial Registration Statement</I></B>.&#148; Any registration statement filed by the Company pursuant to Rule 462(b) under the Securities Act is called the &#147;<B><I>Rule 462(b) Registration Statement</I></B>,&#148; and, from and
after the date and time of filing of the Rule 462(b) Registration Statement, the term &#147;<B><I>Registration Statement</I></B>&#148; shall include any Rule 462(b) Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The prospectus in the form in which it appeared in the Initial Registration Statement is herein called the &#147;<B><I>Base Prospectus</I></B>.&#148; Each
preliminary prospectus supplement to the Base Prospectus (including the Base Prospectus as so supplemented) that described the Securities and the offering thereof, that omitted the Rule 430B Information and that was used prior to the filing of the
final prospectus supplement referred to in the following sentence is herein called a &#147;<B><I>Preliminary Prospectus</I></B>.&#148;<B><I> </I></B>Promptly after the execution and delivery of this Agreement, the Company will prepare and file with
the Commission a final prospectus supplement to the Base Prospectus relating to the Securities and the offering thereof in accordance with the provisions of Rule 430B and Rule 424(b) of the Rules and Regulations. Such final supplemental form of
prospectus (including the Base Prospectus as so supplemented), in the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
form filed with the Commission pursuant to Rule 424(b) under the Securities Act is herein called the &#147;<B><I>Prospectus</I></B>.&#148; Any reference herein to the Base Prospectus, any
Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item&nbsp;12 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act as of the date of
such prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement, all references to the Registration Statement, any Rule 462(b) Registration Statement, the Base
Prospectus, any Preliminary Prospectus, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval System
(&#147;<B><I>EDGAR</I></B>&#148;). All references in this Agreement to financial statements and schedules and other information that is &#147;described,&#148; &#147;contained,&#148; &#147;included&#148; or &#147;stated&#148; in the Registration
Statement, the Base Prospectus, any Preliminary Prospectus or the Prospectus (or other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference
in or otherwise deemed by the Rules and Regulations to be a part of or included in the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Prospectus, as the case may be; and all references in this Agreement to amendments
or supplements to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to mean and include the subsequent filing of any document under the Securities Exchange Act of 1934, as amended (the
&#147;<B><I>Exchange Act</I></B>&#148;), and which is deemed to be incorporated by reference therein or otherwise deemed by the Rules and Regulations to be a part thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b) </B>At the time of the filing of the Initial Registration Statement with the Commission and as of the date hereof, the conditions for use of Form <FONT
STYLE="white-space:nowrap">S-3,</FONT> set forth in the General Instructions thereto, including General Instruction I.B.1., were and have been satisfied. The Initial Registration Statement was declared effective by the Commission under the
Securities Act on April&nbsp;27, 2022. The Company has complied, to the Commission&#146;s satisfaction, with all requests of the Commission for additional or supplemental information. No stop order suspending the effectiveness of the Registration
Statement or any post-effective amendment thereto or the Rule 462(b) Registration Statement, if any, has been issued, and, to the Company&#146;s knowledge, no proceeding for that purpose has been initiated or threatened by the Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(c) </B>For the purposes of this Agreement, the &#147;<B><I>Applicable Time</I></B>&#148; is 7:00 p.m. (Eastern time) on the date of this Agreement. The
Disclosure Package (as defined below) at the Applicable Time complied in all material respects with the requirements of the Securities Act and the Rules and Regulations and did not include any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The preceding sentence does not apply to statements or omissions from the
Disclosure Package made in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of any Underwriter through the Representative expressly for use therein; it being understood and agreed that the only
such information furnished by or on behalf of any Underwriter through the Representative consists of the information described as such in Section&nbsp;10(f). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d) </B>Each part of the Registration Statement, any Rule 462(b) Registration Statement, and any post-effective amendment thereto, at the time that such
part became effective (including each deemed effective date with respect to the Underwriters pursuant to Rule 430B or otherwise under the Securities Act), and at the applicable Time of Delivery (as defined below), and the Prospectus, as of its date
and at the applicable Time of Delivery, complied and will comply in all material respects with the applicable requirements and provisions of the Securities Act, the Rules and Regulations and the Exchange Act (with respect to the documents
incorporated by reference therein pursuant to Item&nbsp;12 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act) and did not and will not contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein not misleading.&nbsp;The Prospectus, as amended or supplemented, as of its date, and at the applicable Time of Delivery, did not and will not contain any untrue statement of a
material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.&nbsp;The representations and warranties set forth in the two immediately
preceding sentences do not apply to statements in or omissions from the Registration Statement, any Rule 462(b) Registration Statement, or any post-effective amendment thereto, or the Prospectus made in reliance upon and in conformity with
information furnished in writing to the Company by or on behalf of any Underwriter through the Representative expressly for use therein; it being understood and agreed that the only such information furnished by or on behalf of any Underwriter
through the Representative consists of the information described as such in Section&nbsp;10(f). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(e) </B>Neither (i)&nbsp;any Issuer General Free Writing Prospectus issued at or prior to the Applicable
Time and set forth on <U>Schedule II</U>, the Statutory Prospectus (as defined in Section&nbsp;1(i) below) at the Applicable Time and the information set forth on <U>Schedule III</U> at the Applicable Time, all considered together (collectively, the
&#147;<B><I>Disclosure Package</I></B>&#148;); nor (ii)&nbsp;any individual Issuer <FONT STYLE="white-space:nowrap">Limited-Use</FONT> Free Writing Prospectus, when considered together with the Disclosure Package, includes or included as of the
Applicable Time any untrue statement of a material fact or omits or omitted as of the Applicable Time to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading.&nbsp;The representations and warranties set forth in the immediately preceding sentence do not apply to statements in or omissions from any Statutory Prospectus or any Issuer Free Writing Prospectus made in reliance upon and in
conformity with information furnished in writing to the Company by or on behalf of any Underwriter through the Representative expressly for use therein; it being understood and agreed that the only such information furnished by or on behalf of any
Underwriter through the Representative consists of the information described as such in Section&nbsp;10(f). As used in this paragraph and elsewhere in this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(i) </B>&#147;<B><I>Statutory Prospectus</I></B>&#148; means the Base Prospectus, as amended and supplemented immediately prior to the Applicable Time,
including any document incorporated by reference therein and any prospectus supplement deemed to be a part thereof, including the final prospectus supplement dated the date hereof. For purposes of this definition, Rule 430B Information contained in
a form of prospectus that is deemed retroactively to be a part of the Registration Statement shall be considered to be included in the Statutory Prospectus as of the actual time that form of prospectus is filed with the Commission pursuant to Rule
424(b) under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(ii) </B>&#147;<B><I>Issuer Free Writing Prospectus</I></B>&#148; means any &#147;issuer free writing
prospectus,&#148; as defined in Rule 433 under the Securities Act, relating to the Securities that (A)&nbsp;is required to be filed with the Commission by the Company; or (B)&nbsp;is exempt from filing pursuant to Rule 433(d)(5)(i) under the
Securities Act because it contains a description of the Securities or of the offering that does not reflect the final terms, or is a &#147;bona fide electronic roadshow,&#148; as defined in Rule 433 of the Rules and Regulations, in each case in the
form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#146;s records pursuant to Rule 433(g) under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(iii) </B>&#147;<B><I>Issuer General Free Writing Prospectus</I></B>&#148; means any Issuer Free Writing Prospectus that is intended for general
distribution to prospective investors, as evidenced by its being specified in <U>Schedule II</U> hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(iv) </B>&#147;<B><I>Issuer <FONT
STYLE="white-space:nowrap">Limited-Use</FONT> Free Writing Prospectus</I></B>&#148; means any Issuer Free Writing Prospectus that is not an Issuer General Free Writing Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(f) </B>Each Issuer Free Writing Prospectus, as of its issue date and at the applicable Time of Delivery, did not, does not and will not include any
information that conflicted, conflicts or will conflict with the information contained in the Registration Statement, any Statutory Prospectus or the Prospectus.&nbsp;The foregoing sentence does not apply to statements in or omissions from any
Issuer Free Writing Prospectus made in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of any Underwriter through the Representative expressly for use therein; it being understood and agreed that
the only such information furnished by or on behalf of any Underwriter through the Representative consists of the information described as such in Section&nbsp;10(f). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(g) </B>Each Issuer Free Writing Prospectus satisfied, as of its issue date and at all subsequent times through the applicable Time of Delivery, all other
conditions to use thereof as set forth in Rules 164 and 433 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(h) </B>The documents incorporated by reference in the
Disclosure Package and in the Prospectus, when they became effective or were filed with the Commission, as the case may be, conformed in all material respects to the requirements of the Securities Act or the Exchange Act, as applicable, and were
filed on a timely basis with the Commission, and none of such documents contained an untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances under which they
were made, not misleading; any further documents so filed and incorporated by reference in the Disclosure Package or in the Prospectus, when such documents are filed with the Commission, will conform in all material respects to the requirements of
the Exchange Act, and will not contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(i) </B>The Company has been duly organized, is validly existing and in good standing as a corporation or
other business entity under the laws of its jurisdiction of organization and is duly qualified to do business and in good standing as a foreign corporation or other business entity in each jurisdiction in which its ownership or lease of property or
the conduct of its businesses requires such qualification, except where the failure to be so qualified or in good standing could not, in the aggregate, (i)&nbsp;reasonably be expected to have a material adverse effect on the condition (financial or
otherwise), results of operations, stockholders&#146; equity, properties, business or prospects of the Company taken as a whole or (ii)&nbsp;impair in any material respect the ability of the Company to perform its obligations under this Agreement or
the Warrants or to consummate any transactions contemplated by this Agreement, the Warrants, the Disclosure Package or the Prospectus (a &#147;<B><I>Material Adverse Effect</I></B>&#148;); the Company has all power and authority necessary to own or
hold its properties and to conduct the businesses in which it is engaged. The Company does not own or control, directly or indirectly, any corporation, association or other entity other than the Subsidiaries listed in Exhibit 21 to the
Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the most recent fiscal year (collectively, the &#147;<B><I>Subsidiaries</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(j) </B>The Company has an authorized capitalization as set forth in the Base Prospectus under the caption &#147;Description of our Common Stock,&#148; and
all of the issued shares of capital stock of the Company have been duly authorized and validly issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> conform in all material respects to the description thereof contained
in the Base Prospectus and were issued in compliance in all material respects with federal and state securities laws and not in violation of any preemptive right, resale right, right of first refusal or similar right. All of the Company&#146;s
options, warrants and other rights to purchase or exchange any securities for shares of the Company&#146;s capital stock have been duly authorized and validly issued, and were issued in compliance in all material respects with federal and state
securities laws. All of the issued shares of capital stock of each Subsidiary of the Company have been duly authorized and validly issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and, except as otherwise described
in the Registration Statement, the Disclosure Package and the Prospectus, are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims, except for such liens, encumbrances, equities or claims as
could not, in the aggregate, reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(k) </B>The Securities to be issued and sold by the Company to
the Underwriters hereunder have been duly authorized and, upon payment and delivery in accordance with this Agreement, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> will conform in all material
respects to the description thereof contained in the Base Prospectus, will be issued in compliance with federal and state securities laws and will be free of statutory and contractual preemptive rights, rights of first refusal and similar rights.
The Warrant Shares to be issued by the Company upon exercise of the Warrants, as provided therein, have been duly and validly authorized and, when issued and delivered upon exercise of the Warrants, will be duly and validly issued, fully paid and <FONT
STYLE="white-space:nowrap">non-assessable.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(l) </B>The Company has all requisite corporate power and authority to execute, deliver and perform
its obligations under this Agreement. This Agreement has been duly and validly authorized, executed and delivered by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(m) </B>The
execution, delivery and performance of this Agreement and the Warrants by the Company, the consummation of the transactions contemplated hereby and the application of the proceeds from the sale of the Securities and the Warrant Shares as described
under &#147;Use of Proceeds&#148; in the Preliminary Prospectus and the Prospectus will not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, impose any lien, charge or encumbrance upon any property or
assets of the Company, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement, license or other agreement or instrument to which the Company or any of its Subsidiaries is a party or by which the Company or any of its
Subsidiaries is bound or to which any of the property or assets of the Company or any of its Subsidiaries is subject; (ii)&nbsp;result in any violation of the provisions of the charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> (or similar
organizational documents) of the Company or any of its Subsidiaries; or (iii)&nbsp;result in any violation of any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over the Company or any of its
Subsidiaries or any of their properties or assets, except in the case of clauses (i)&nbsp;and (iii), to the extent any such conflict, breach, violation, lien, charge, encumbrance or default could not, in the aggregate, reasonably be expected to have
a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(n) </B>No consent, approval, authorization or order of, or filing or registration with, any court or
governmental agency or body having jurisdiction over the Company or any of its Subsidiaries or any of their properties or assets is required for the execution, delivery and performance of this Agreement by the Company, the consummation of the
transactions contemplated hereby, the application of the proceeds from the sale of the Securities and the Warrant Shares as described under &#147;Use of Proceeds&#148; in the Preliminary Prospectus and the Prospectus, except for the registration of
the Securities under the Securities Act and such consents, approvals, authorizations, registrations or qualifications as may be required under the Exchange Act, the Nasdaq Stock Market Rules and applicable state securities laws in connection with
the purchase and sale of the Securities by the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(o) </B>There are no contracts, agreements or understandings between the Company and any
person granting such person the right to require the Company to file a registration statement under the Securities Act with respect to any securities of the Company owned or to be owned by such person or to require the Company to include such
securities in the securities registered pursuant to the Registration Statement or in any securities being registered pursuant to any other registration statement filed by the Company under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(p) </B>The Company has not sold or issued any securities that would be integrated with the offering of the Securities contemplated by this Agreement
pursuant to the Securities Act, the Rules and Regulations or the interpretations thereof by the Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(q) </B>Neither the Company nor any of its
Subsidiaries has sustained, since the date of the latest audited financial statements included or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, any loss or interference with its business from
fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, and since such date, there has not been (i)&nbsp;any change in the capital stock or long-term
debt of the Company or any of its Subsidiaries except as described in the Registration Statement, the Disclosure Package and the Prospectus; or (ii)&nbsp;any adverse change, or any development involving a prospective adverse change, in or affecting
the condition (financial or otherwise), results of operations, stockholders&#146; equity, properties, management, business or prospects of the Company taken as a whole, in each case set forth in this section (q)&nbsp;except as could not, in the
aggregate, reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(r) </B>The Company has good and marketable title to all real property and good
and marketable title to all material personal property (other than Intellectual Property, which is addressed below) described in the Registration Statement, the Disclosure Package or the Prospectus as being owned by it, in each case free and clear
of all liens, encumbrances and defects except such as are described in the Registration Statement, the Disclosure Package and the Prospectus or such as do not materially affect the value of such property and do not materially interfere with the use
made of such property by the Company; and any real property and buildings held under lease by the Company are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not materially interfere with
the use made of such property and buildings by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(s) </B>Since the date as of which information is given in the Preliminary Prospectus and
Prospectus, the Company has not (i)&nbsp;incurred any liability or obligation, direct or contingent, other than liabilities and obligations that were incurred in the ordinary course of business, (ii)&nbsp;entered into any material transaction not in
the ordinary course of business or (iii)&nbsp;declared or paid any dividend on its capital stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(t) </B>The historical financial statements
(including the related notes and supporting schedules) included or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus comply as to form in all material respects with the requirements of Regulation <FONT
STYLE="white-space:nowrap">S-X</FONT> under the Securities Act and present fairly the financial condition, results of operations and cash flows of the entities purported to be shown thereby at the dates and for the periods indicated and have been
prepared in conformity with accounting principles generally accepted in the United States applied on a consistent basis throughout the periods involved. All <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial information included in the
Registration Statement, the Disclosure Package and the Prospectus complies in all materials respects with the requirements of Regulation G and Item&nbsp;10 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(u) </B>RSM US LLP, who has certified certain financial statements of the Company and its consolidated
subsidiaries, whose report appears in the Registration Statement, the Disclosure Package and the Prospectus or are incorporated by reference therein and who has delivered the initial letter referred to in Section&nbsp;9(f) hereof, is, to the
knowledge of the Company, an independent public accountant as required by the Securities Act and the Rules and Regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(v) </B>The statistical
and market-related data included or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate in all material
respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(w) </B>The Company is not, and as of the applicable Time of Delivery after giving effect to the offer and sale of the Securities and the
application of the proceeds therefrom as described under &#147;Use of Proceeds&#148; in the Preliminary Prospectus and the Prospectus, will not be, (i)&nbsp;an &#147;investment company&#148; within the meaning of such term under the Investment
Company Act of 1940, as amended (the &#147;<B><I>Investment Company Act</I></B>&#148;), and the rules and regulations of the Commission thereunder; or (ii)&nbsp;a &#147;business development company&#148; (as defined in Section&nbsp;2(a)(48) of the
Investment Company Act). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(x)</B> Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, there are no legal or
governmental proceedings pending to which the Company or any of its Subsidiaries is a party or of which any property or assets of the Company or any of its Subsidiaries is the subject that could, in the aggregate, reasonably be expected to have a
Material Adverse Effect or could, in the aggregate, reasonably be expected to have a material adverse effect on the performance by the Company of this Agreement or the consummation by the Company of the transactions contemplated hereby; and to the
Company&#146;s knowledge, no such proceedings are threatened or contemplated by governmental authorities or others. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(y) </B>No relationship, direct or
indirect, exists between or among the Company, on the one hand, and the directors, officers, stockholders, customers or suppliers of the Company, on the other hand, that is required to be described in the Registration Statement, the Disclosure
Package and the Prospectus that is not so described. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(z) </B>No labor disturbance by the employees of the Company or its Subsidiaries exists or, to
the knowledge of the Company, is imminent that could reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(aa)</B>&nbsp;(i) Each &#147;employee
benefit plan&#148; (within the meaning of Section&nbsp;3(3) of the Employee Retirement Security Act of 1974, as amended (&#147;<B><I>ERISA</I></B>&#148;)) for which the Company or any member of its &#147;Controlled Group&#148; (defined as any
organization which is a member of a controlled group of corporations within the meaning of Section&nbsp;414 of the Internal Revenue Code of 1986, as amended (the &#147;<B><I>Code</I></B>&#148;)) would have any liability (each a
&#147;<B><I>Plan</I></B>&#148;) has been maintained in compliance in all material respects with its terms and with the requirements of all applicable statutes, rules and regulations including ERISA and the Code; (ii)&nbsp;with respect to each Plan
subject to Title IV of ERISA (a)&nbsp;no &#147;reportable event&#148; (within the meaning of Section&nbsp;4043(c) of ERISA) has occurred or is reasonably expected to occur, (b)&nbsp;no &#147;accumulated funding deficiency&#148; (within the meaning
of Section&nbsp;302 of ERISA or Section&nbsp;412 of the Code), whether or not waived, has occurred or is reasonably expected to occur, (c)&nbsp;the fair market value of the assets under each Plan exceeds the present value of all benefits accrued
under such Plan (determined based on those assumptions used to fund such Plan) and (d)&nbsp;neither the Company nor any member of its Controlled Group has incurred, or reasonably expects to incur, any liability under Title IV of ERISA (other than
contributions to the Plan or premiums to the Pension Benefit Guaranty Corporation in the ordinary course and without default) in respect of a Plan (including a &#147;multiemployer plan,&#148; within the meaning of Section&nbsp;4001(c)(3) of ERISA);
and (iii)&nbsp;each Plan that is intended to be qualified under Section&nbsp;401(a) of the Code is so qualified and, to the knowledge of the Company, nothing has occurred, whether by action or by failure to act, which would cause the loss of such
qualification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(bb) </B>The Company and its Subsidiaries carry, or are covered by, insurance issued by insurers of nationally recognized financial
responsibility in such amounts and covering such risks as is adequate for the conduct of their business and the value of their properties and as is customary for companies engaged in similar businesses in similar industries. All such insurance is
outstanding and in force on the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(cc) </B>The Company and each of its Subsidiaries have filed all federal, state, local and foreign income
and franchise tax returns required to be filed through the date hereof, subject to permitted extensions, and have paid all taxes due thereon, and no tax deficiency has been determined adversely to the Company or any of its Subsidiaries, nor does the
Company have any knowledge of any tax deficiencies that could, in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(dd) </B>There are no transfer taxes or other similar fees or charges under federal law or the laws of
any state, or any political subdivision thereof, required to be paid in connection with the execution and delivery of this Agreement or the issuance by the Company or sale by the Company of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(ee) </B>Neither the Company nor any of its Subsidiaries (i)&nbsp;is in violation of its charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> (or
similar organizational documents), (ii)&nbsp;is in default, and, to the knowledge of the Company, no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term,
covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement, license or other agreement or instrument to which it is a party or by which it is bound or to which any of its properties or assets is subject or
(iii)&nbsp;is in violation of any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over it or its property or assets or has failed to obtain any license, permit, certificate, franchise or other
governmental authorization or permit necessary to the ownership of its property or to the conduct of its business, except in the case of clauses (ii)&nbsp;and (iii), to the extent any such conflict, breach, violation or default could not, in the
aggregate, reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(ff) </B>There is and has been no failure on the part of the Company and, to the
knowledge of the Company, of any of the Company&#146;s directors or officers, in their capacities as such, to comply in all material respects with the provisions of the Sarbanes-Oxley Act of 2002 (the &#147;<B><I>Sarbanes-Oxley Act</I></B>&#148;)
and the rules and regulations promulgated in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(gg) </B>The Company and each of its Subsidiaries have such permits, licenses,
franchises, certificates of need and other approvals or authorizations of governmental or regulatory authorities (&#147;<B><I>Permits</I></B>&#148;) as are necessary under applicable law to own their properties and conduct their businesses in the
manner described in the Registration Statement, the Disclosure Package and the Prospectus, except for any of the foregoing that could not, in the aggregate, reasonably be expected to have a Material Adverse Effect; each of the Company and its
Subsidiaries has fulfilled and performed all of its obligations with respect to the Permits, and no event has occurred that allows, or after notice or lapse of time would allow, revocation or termination thereof or results in any other impairment of
the rights of the holder or any such Permits, except for any of the foregoing that could not reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(hh) </B>To the knowledge of the Company, the Company and its Subsidiaries own, possess, or can acquire on reasonable terms, all patents, patent
applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, <FONT STYLE="white-space:nowrap">know-how</FONT> and other intellectual property (collectively,
&#147;<B><I>Intellectual Property</I></B>&#148;) necessary for the conduct of their business as now conducted or as proposed in the Registration Statement and Prospectus to be conducted except as such failure to own, possess, or acquire such rights
would not have a Material Adverse Effect. Except as set forth in the Registration Statement, the Disclosure Package or the Prospectus: (i)&nbsp;to the knowledge of the Company or any of its Subsidiaries, there is no infringement, misappropriation or
violation by third parties of any such Intellectual Property, except as such infringement, misappropriation or violation would not have a Material Adverse Effect; (ii)&nbsp;there is no pending or, to the knowledge of the Company, threatened action,
suit, proceeding or claim by others challenging the rights of the Company in or to any such Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim; (iii)&nbsp;the Intellectual Property
owned by the Company and to the knowledge of the Company, the Intellectual Property licensed to the Company has not been adjudged invalid or unenforceable, in whole or in part, and there is no pending or, to the knowledge of the Company, threatened
action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property, and the Company or any of its Subsidiaries are unaware of any facts which would form a reasonable basis for any such claim;
(iv)&nbsp;there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others that the Company or any of its Subsidiaries infringe, misappropriate or otherwise violate any Intellectual Property or other
proprietary rights of others, the Company or any of its Subsidiaries have not received any written notice of such claim and the Company and its Subsidiaries are unaware of any other fact which would form a reasonable basis for any such claim; and
(v)&nbsp;to the knowledge of the Company or any of its Subsidiaries, no employee of the Company or any of its Subsidiaries is in or has ever been in violation of any term of any employment contract, patent disclosure agreement, invention assignment
agreement, <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement, <FONT STYLE="white-space:nowrap">non-solicitation</FONT> agreement, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
nondisclosure agreement or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&#146;s employment with the Company or actions
undertaken by the employee while employed with the Company except where such violation would not, individually or in the aggregate, result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(ii) </B>Except as described in Registration Statement, the Disclosure Package and the Prospectus, (i)&nbsp;there are no proceedings that are pending, or
known to be contemplated, against the Company or any of its Subsidiaries under any laws, regulations, ordinances, rules, orders, judgments, decrees, permits or other legal requirements of any governmental authority, including without limitation any
international, national, state, provincial, regional, or local authority, relating to the protection of human health or safety, the environment, or natural resources, or to hazardous or toxic substances or wastes, pollutants or contaminants
(&#147;<B><I>Environmental Laws</I></B>&#148;) in which a governmental authority is also a party, other than such proceedings regarding which it is reasonably believed no monetary sanctions of $100,000 or more will be imposed, (ii)&nbsp;the Company
and its Subsidiaries are not aware of any issues regarding compliance with Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or contaminants, that could
reasonably be expected to have a Material Adverse Effect, and (iii)&nbsp;none of the Company and its Subsidiaries anticipates capital expenditures relating to Environmental Laws that would be material to the Company and its Subsidiaries taken as a
whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(jj) </B>No subsidiary of the Company is currently prohibited, directly or indirectly, from paying any dividends to the Company, from making
any other distribution on such subsidiary&#146;s capital stock, from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary&#146;s property or assets to the Company or any other
subsidiary of the Company, except as described in the Registration Statement, the Disclosure Package and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(kk) </B>Neither the Company
nor any of its Subsidiaries, nor, to the knowledge of the Company, any director, officer, agent, employee or other person associated with or acting on behalf of the Company or any of its Subsidiaries, has (i)&nbsp;used any corporate funds for any
unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii)&nbsp;made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds;
(iii)&nbsp;violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977; or (iv)&nbsp;made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(ll) </B>The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions to which the Company or its Subsidiaries are subject, the rules and regulations thereunder and
any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#147;<B><I>Money Laundering Laws</I></B>&#148;), except as would not reasonably be expected to result in a
Material Adverse Effect, and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its Subsidiaries with respect to the Money Laundering Laws is pending or,
to the knowledge of the Company, threatened, except, in each case, as would not reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(mm)
</B>Neither the Company nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury
Department (&#147;<B><I>OFAC</I></B>&#148;); and the Company will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner or other person or
entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(nn) </B>The Company
has not distributed and, prior to the later to occur of any Time of Delivery and completion of the distribution of the Securities, will not distribute any offering material in connection with the offering and sale of the Securities other than the
Preliminary Prospectus, the Prospectus and any Issuer Free Writing Prospectus to which the Representative has consented in accordance with Section&nbsp;7(a). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(oo) </B>The Company has not taken and will not take, directly or indirectly, any action designed to or
that has constituted or that could reasonably be expected to cause or result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(pp) </B>The Shares and Warrant Shares have been approved for listing, subject to official notice of issuance, on the Nasdaq Capital Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(qq) </B>There are no statutes, regulations, contracts or documents that are required to be described in the Registration Statement, the Disclosure Package
and the Prospectus or to be filed as exhibits to the Registration Statement by the Securities Act or by the Rules and Regulations that have not been so described or filed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(rr) </B>At the earliest time after the filing of the Registration Statement that the Company or another offering participant made a <I>bona fide</I> offer
(within the meaning of Rule 164(h)(2) under the Securities Act) of the Securities and at the date hereof, the Company was not and is not an &#147;ineligible issuer,&#148; as defined in Rule 405 under the Securities Act, in the preceding three years
not having been convicted of a felony or misdemeanor or having been made the subject of a judicial or administrative decree or order as described in Rule 405 (without taking account of any determination by the Commission pursuant to Rule 405 that it
is not necessary that the Company be considered an ineligible issuer), nor an &#147;excluded issuer&#148; as defined in Rule 164 under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(ss) </B>The Common Stock of the Company is registered pursuant to Section&nbsp;12(b) of the Exchange Act and is listed on the Nasdaq Capital Market under
the ticker symbol &#147;KOPN.&#148; The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Capital Market
nor has the Company received any notice that it is not in compliance with the listing or maintenance requirements of the Nasdaq Capital Market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(tt)
</B>Except as described in the Registration Statement, the Disclosure Package or the Prospectus, neither the Company nor, to the Company&#146;s knowledge, the Company&#146;s officers, directors or any of its affiliates (within the meaning of FINRA
Conduct Rule 5121(f)(1)), directly or indirectly controls, is controlled by, or is under common control with, or is an associated person (within the meaning of Article I, Section&nbsp;1(gg) of the <FONT STYLE="white-space:nowrap">By-laws</FONT> of
FINRA) of, any member firm of FINRA.&nbsp;&nbsp;&nbsp;&nbsp;To enable the Underwriters to rely on Rule 5110(j)(6) of FINRA, the Company represents that, (i)&nbsp;as of a date within 60 days of the date of this Agreement, the Company had a <FONT
STYLE="white-space:nowrap">non-affiliate,</FONT> public common equity float of at least $150&nbsp;million or a <FONT STYLE="white-space:nowrap">non-affiliate,</FONT> public common equity float of at least $100&nbsp;million and annual trading volume
of at least three million shares and (ii)&nbsp;as of the date of this Agreement, the Company has been subject to the Exchange Act reporting requirements for a period of at least 36 months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(uu) </B>The Company maintains a system of internal control over financial reporting (as such term is defined in
<FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(f)</FONT> under the Exchange Act) that complies in all material respects with the requirements of the Exchange Act and has been designed by the Company&#146;s principal executive officer and
principal financial officer, or under their supervision, to provide reasonable assurances that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorization; (ii)&nbsp;transactions are recorded as
necessary to permit preparation of financial statements in conformity with generally accepted accounting principles in the United States (&#147;<B><I>GAAP</I></B>&#148;) and to maintain accountability for assets; (iii)&nbsp;access to assets is
permitted only in accordance with management&#146;s general or specific authorization; and (iv)&nbsp;the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any
differences. Except as described in the Registration Statement, the Disclosure Package and the Prospectus, the Company&#146;s internal control over financial reporting is effective in all material respects based on criteria established in Internal
Control&#151;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. The Company&#146;s board of directors has, subject to the exceptions, cure periods and the phase in periods specified in the applicable
stock exchange rules (&#147;<B><I>Exchange Rules</I></B>&#148;), validly appointed an audit committee to oversee internal accounting controls whose composition satisfies the applicable requirements of the Exchange Rules and the Company&#146;s board
of directors and/or the audit committee has adopted a charter that satisfies the requirements of the Exchange Rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(vv) </B>Except as described in
the Registration Statement, the Disclosure Package and the Prospectus, neither the Company&#146;s board of directors nor the audit committee has been informed, nor, to the knowledge of the Company, is any director of the Company aware, and the
Company is not aware, of (i)&nbsp;during the past 36 months, any &#147;material weaknesses&#148; (as defined by the Public Company Accounting Oversight Board) in the design or operation of the Company&#146;s internal controls that could adversely
affect the Company&#146;s ability to record, process, summarize and report financial data; or (ii)&nbsp;any fraud, whether or not material, that involves management or other employees of the Company who have a significant role in the Company&#146;s
internal controls. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(ww) </B>Except as described in the Registration Statement, the Disclosure Package and the Prospectus,
since the date of the latest audited financial statements of the Company included in the Prospectus, there has been no change in the Company&#146;s internal control over financial reporting that has materially adversely affected, or is reasonably
likely to materially adversely affect, the Company&#146;s internal control over financial reporting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(xx) </B>The Company maintains disclosure
controls and procedures (as such term is defined in Rule <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> under the Exchange Act) that comply with the requirements of the Exchange Act, such disclosure controls and procedures have been designed to
ensure that material information relating to the Company is made known to the Company&#146;s principal executive officer and principal financial officer by others within those entities, and such disclosure controls and procedures are effective in
all material respects. The Company has utilized such controls and procedures in preparing and evaluating the disclosures in the Registration Statement, the Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(yy) </B>Except as otherwise contemplated by this Agreement or as disclosed in the Registration Statement, the Disclosure Package or the Prospectus, no
person is entitled to receive from the Company a brokerage commission, finder&#146;s fee or other like payment in connection with the transactions contemplated herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(zz) </B>The Company does not do business with the government of Cuba or with any person located in Cuba within the meaning of Section&nbsp;517.075,
Florida Statutes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(aaa)</B> Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus (i)(x) to the Company&#146;s
knowledge, there has been no security breach, attack or other compromise of or relating to any of the Company&#146;s or any of its Subsidiaries&#146; information technology and computer systems, networks, hardware, software, data (including the data
of their respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of them), equipment or technology (collectively, &#147;<B><I>IT Systems and Data</I></B>&#148;) and (y)&nbsp;the Company and its
Subsidiaries have not been notified in writing of, and have no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise to their IT Systems and Data, except as would not, in the case
of this clause (i), individually or in the aggregate, have a Material Adverse Effect; (ii)&nbsp;the Company and its Subsidiaries have been in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any
court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to (x)&nbsp;the privacy and security of IT Systems and Data, (y)&nbsp;the protection of such IT Systems and Data from unauthorized
use, access, misappropriation or modification and (z)&nbsp;the collection, use, transfer, storage, disposal and disclosure by the Company and its Subsidiaries of personally identifiable information and/or any other information collected from or
provided by third parties, except as would not, in the case of this clause (ii), individually or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and its Subsidiaries have implemented commercially reasonable backup and
disaster recovery and security plans, procedures and facilities for their respective businesses consistent with industry standards and practices; and (iv)&nbsp;the Company and its Subsidiaries have taken commercially reasonable steps to protect the
IT Systems and Data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. </B>Subject to the terms and conditions herein set forth, (a)&nbsp;the Company agrees to sell to each of the Underwriters, and
each of the Underwriters agrees, severally and not jointly, to purchase from the Company, at a purchase price per share of $0.94 (the &#147;<B><I>Purchase Price</I></B>&#148;), the number of Firm Shares (to be adjusted by the Representative so as to
eliminate fractional shares) determined by multiplying the aggregate number of Firm Shares to be sold by the Company by a fraction, the numerator of which is the aggregate number of Firm Shares to be purchased by such Underwriter as set forth
opposite the name of such Underwriter in <U>Schedule I</U> hereto and the denominator of which is the aggregate number of Firm Shares to be purchased by all of the Underwriters from the Company hereunder; (b)&nbsp;each Underwriter agrees, severally
and not jointly, to purchase from the Company the number of Warrants set forth opposite the name of such Underwriter in <U>Schedule</U><U></U><U>&nbsp;I</U> hereto, at a purchase price of $0.93 per share underlying the Warrant, the number of
Warrants (to be adjusted by the Representative so as to eliminate fractional shares) determined by multiplying the aggregate number of Warrants to be sold by the Company by a fraction, the numerator of which is the aggregate number of Warrants to be
purchased by such Underwriter as set forth opposite the name of such Underwriter in <U>Schedule I</U> hereto and the denominator of which is the aggregate number of Warrants to be purchased by all of the Underwriters from the Company hereunder; and
(c)&nbsp;in the event and to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
extent that the Underwriters shall exercise the election to purchase Option Shares as provided below, the Company agrees to sell to each of the Underwriters, and each of the Underwriters agrees,
severally and not jointly, to purchase from the Company, at the Purchase Price, the number of Option Shares (to be adjusted by the Representative so as to eliminate fractional shares) determined by multiplying (x)&nbsp;the product of the number of
Option Shares as to which such election shall have been exercised by (y)&nbsp;the fraction set forth in clause (a)&nbsp;above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company hereby grants
to the Underwriters the right to purchase at their election up to 3,000,000 Option Shares at the Purchase Price. The Underwriters may exercise their option to acquire Option Shares in whole or in part from time to time only by written notice from
the Representative to the Company, given within a period of 30 calendar days after the date of this Agreement and setting forth the aggregate number of Option Shares to be purchased and the date on which such Option Shares are to be delivered, as
determined by the Representative, but in no event earlier than the Firm Shares Time of Delivery or, unless the Representative and the Company otherwise agree in writing, earlier than two or later than ten business days after the date of such notice.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. </B>Upon the authorization by the Representative of the release of the Firm Shares, the several Underwriters propose to offer the Firm Shares for
sale upon the terms and conditions set forth in the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. (a) </B>The Firm Shares to be purchased by each Underwriter hereunder will be
represented by one or more definitive global shares in book-entry form, which will be deposited by or on behalf of the Company with the Depository Trust Company (&#147;<B><I>DTC</I></B>&#148;) or its designated custodian. The Company will deliver
the Firm Shares as directed by the Representative, for the account of each Underwriter, against payment by or on behalf of such Underwriter of the purchase price therefor by wire transfer of Federal <FONT STYLE="white-space:nowrap">(same-day)</FONT>
funds to the account specified by the Company to the Representative, by causing DTC to credit the Firm Shares to the account of the Representative at DTC. The time and date of such delivery and payment shall be 10:00 a.m., New York time, on
January&nbsp;27, 2023, or such other time and date as the Representative and the Company may agree upon in writing. Such time and date for delivery of the Firm Shares is herein called the &#147;<B><I>Firm Shares Time of Delivery</I></B>.&#148; The
Warrants shall be delivered to the Representative in definitive form, registered in such names and in such denominations as the Representative shall request in writing not later than the Firm Shares Time of Delivery. The Warrants will be made
available for inspection by the Representative on the business day prior to the Firm Shares Time of Delivery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b) </B>The documents to be delivered at
the Firm Shares Time of Delivery by or on behalf of the parties hereto pursuant to Section&nbsp;9 hereof, including the cross receipt for the Securities and any additional documents requested by the Underwriters pursuant to Section&nbsp;9(o) hereof,
will be delivered electronically or at such other place as the parties mutually agree, and the Securities will be delivered at the office of DTC or its designated custodian (the &#147;<B><I>Designated Office</I></B>&#148;), all at such Firm Shares
Time of Delivery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(c) </B>For the purposes of this Agreement, &#147;<B><I>New York Business Day</I></B>&#148; shall mean each Monday, Tuesday,
Wednesday, Thursday and Friday which is not a day on which banking institutions in New York City are generally authorized or obligated by law or executive order to close. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d) </B>Each time for the delivery of and payment for the Option Shares, being herein referred to as an &#147;<B><I>Option Shares Time of
Delivery</I></B>&#148;, which may be the Firm Shares Time of Delivery, shall be determined by the Representative as provided above. The Option Shares to be purchased by each Underwriter hereunder will be represented by one or more definitive global
shares in book-entry form, which will be deposited by or on behalf of the Company with DTC or its designated custodian. The Company will deliver the Option Shares as directed by the Representative, for the account of each Underwriter, against
payment by or on behalf of such Underwriter of the purchase price therefor by wire transfer of Federal <FONT STYLE="white-space:nowrap">(same-day)</FONT> funds to the account specified by the Company to the Representative, by causing DTC to credit
the Option Shares to the account of the Representative at DTC at the applicable Option Shares Time of Delivery. The time and date of such delivery and payment shall be 10:00 a.m., New York time, on such time and date as directed by the
Representative. The documents to be delivered at the Option Shares Time of Delivery by or on behalf of the parties hereto pursuant to Section&nbsp;9 hereof, including the cross receipt for the Option Shares and any additional documents requested by
the Underwriters pursuant to Section&nbsp;9(o) hereof, will be delivered consistent with the provisions of clause (b)&nbsp;above, and the Option Shares will be delivered at the Designated Office, all at such Option Shares Time of Delivery. In this
Agreement, references to &#147;<B><I>Time of Delivery</I></B>&#148; shall refer to either the Firm Shares Time of Delivery or Option Shares Time of Delivery as the context shall indicate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. </B>The Company acknowledges and agrees that (a)&nbsp;the purchase and sale of the Securities pursuant
to this Agreement is an <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> commercial transaction between the Company and the several Underwriters; (b)&nbsp;in connection therewith and with the process leading to such transaction, each
Underwriter is acting solely as a principal and not the agent or fiduciary of the Company; (c)&nbsp;no Underwriter has assumed an advisory or fiduciary responsibility in favor of the Company with respect to the offering contemplated hereby or the
process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company on other matters) or any other obligation to the Company except the obligations expressly set forth in this Agreement; (d)&nbsp;the
Company has consulted its own legal and financial advisors to the extent it deemed appropriate and is capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated by this
Agreement; and (e)&nbsp;the Company has been advised that each of the Underwriters and its respective affiliates are engaged in a broad range of transactions which may involve interests that differ from those of the Company and that the Underwriters
have no obligation to disclose such interest and transactions to the Company by virtue of any fiduciary, advisory or agency relationship. The Company agrees that it will not claim that any Underwriter has rendered advisory services of any nature or
respect, or owes a fiduciary duty, to the Company in connection with such transaction or the process leading thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement supersedes all prior
agreements and understandings (whether written or oral) between the Company, on the one hand, and the Underwriters, or any of them, on the other, with respect to the subject matter hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the Company and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by
jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. </B>The Company agrees with each
of the Underwriters: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(a) </B>To prepare the Prospectus in a form approved by the Representative and to file such Prospectus pursuant to
Rule&nbsp;424(b) under the Securities Act not later than the Commission&#146;s close of business on the second New York Business Day following the execution and delivery of this Agreement, or, if applicable, such earlier time as may be required by
Rule 430A(a)(3) under the Securities Act; during the period beginning on the date hereof and ending on the later of the applicable Time of Delivery and the date, as determined in the opinion of counsel for the Underwriters, that the Prospectus is no
longer required by law to be delivered (assuming the absence of Rule 172 of the Securities Act) in connection with the sales by an Underwriter (the &#147;<B><I>Prospectus Delivery Period</I></B>&#148;), to furnish to the Underwriters for review a
copy of any proposed amendment or supplement to the Registration Statement, the Disclosure Package or the Prospectus; to make no amendment or supplement to the Registration Statement, the Disclosure Package or the Prospectus during the Prospectus
Delivery Period to which the Underwriters or their counsel reasonably objects; to advise the Underwriters, promptly after the Company receives notice thereof, of the time when any amendment to the Registration Statement has been filed or becomes
effective or any supplement to the Disclosure Package or Prospectus or any amended Prospectus has been filed and to furnish the Underwriters with copies thereof; to file promptly all material required to be filed by the Company with the Commission
pursuant to Rule 433(d) under the Securities Act; to advise the Underwriters, promptly after it receives notice or obtains knowledge thereof, of the issuance by the Commission of any stop order or of any order suspending the effectiveness of the
Registration Statement or any post-effective amendment thereto or preventing or suspending the use of any Preliminary Prospectus, the Disclosure Package, the Prospectus or any Issuer Free Writing Prospectus, of the suspension of the qualification of
the Securities for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding for any such purpose or of any request by the Commission for the amending or supplementing of the Registration Statement, the Disclosure
Package or the Prospectus or for additional information; and to use its best efforts to prevent, and to promptly use its best efforts to obtain the withdrawal of, any such order; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b) </B>During the Prospectus Delivery Period, to comply with all requirements imposed upon it by the Securities Act and by the Rules and Regulations and
by the Exchange Act so far as necessary to permit the continuance of sales of or dealings in the Securities as contemplated by the provisions of this Agreement, the Disclosure Package and the Prospectus; if, during the Prospectus Delivery Period,
any event shall occur or condition shall exist as a result of which the Prospectus (or if the Prospectus is not yet available to prospective purchasers, the Disclosure Package) would include an untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amend or supplement the Registration Statement or supplement the Prospectus (or, if the Prospectus is not yet available to prospective purchasers, the Disclosure Package) to comply with the
Securities Act or to file under the Exchange Act any document which would be deemed to be incorporated by reference in the Prospectus in order to comply with the Securities Act or the Exchange Act, to promptly notify the Underwriters and to amend or
supplement the Registration Statement or supplement the Prospectus (or, if the Prospectus is not yet available to prospective purchasers, the Disclosure Package) or file such document (at the expense of the Company) so as to correct such statement
or omission or effect such compliance; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(c) </B>Promptly from time to time to take such action as the Underwriters may reasonably request to qualify
the Securities for offering and sale under the securities laws of such jurisdictions as the Underwriters may reasonably request and to comply with such laws so as to permit the continuance of sales and dealings therein in such jurisdictions for as
long as may be necessary to complete the distribution of the Securities, <I>provided</I> that in connection therewith the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any
jurisdiction or to subject itself to taxation in any such jurisdiction in which it was not otherwise subject to taxation; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d) </B>To furnish, at its
own expense, to the Underwriters and counsel for the Underwriters copies of the Registration Statement, and to the Underwriters and any dealer the Preliminary Prospectus, the Disclosure Package, the Prospectus, any Issuer Free Writing Prospectus and
all amendments and supplements to such documents, in each case as soon as available and in such quantities as the Underwriters may from time to time reasonably request; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(e) </B>To make generally available to its securityholders as soon as practicable, an earnings statement of the Company (which need not be audited)
complying with the last paragraph of Section&nbsp;11(a) of the Securities Act; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(f) </B>During the period beginning from the date hereof and continuing
to and including the date 90 days after the date of the Prospectus (the &#147;<B><I><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period</I></B>&#148;), not to (i)&nbsp;offer, sell, contract to sell or otherwise dispose of, except as provided
hereunder, any securities of the Company, including but not limited to any securities that are convertible into or exchangeable for, or that represent the right to receive, shares of Common Stock or any such substantially similar securities; or
(ii)&nbsp;enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of Common Stock or any such other securities, whether any such transaction described in clause (i)&nbsp;or
(ii)&nbsp;above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise, other than (a)&nbsp;pursuant to equity incentive plans (as may be amended during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period)
and employee benefit plans existing on the date of this Agreement, or (b)&nbsp;upon the conversion, exercise or exchange of convertible, exercisable or exchangeable securities outstanding as of the date of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(g) </B>To issue stop transfer instructions to the transfer agent for the Common Stock with respect to any transaction or contemplated transaction that
would constitute a breach of or default under the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements required by Section&nbsp;9(j); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(h)
</B>During a period of three years from the effective date of the Registration Statement, unless otherwise publicly available in electronic format on the website of the Company or the Commission, to furnish to its shareholders as soon as practicable
after the end of each fiscal year an annual report (including a balance sheet and statements of income, stockholders&#146; equity and cash flows of the Company certified by independent public accountants) and, as soon as practicable after the end of
each of the first three quarters of each fiscal year (beginning with the fiscal quarter ending after the effective date of the Registration Statement), to make available to its shareholders summary financial information of the Company for such
quarter in reasonable detail; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(i) </B>During a period of three years from the effective date of the Registration Statement, unless otherwise publicly
available in electronic format on the website of the Company or the Commission, to furnish to the Underwriters copies of all reports or other communications (financial or other) furnished to shareholders, and to deliver to the Underwriters
(i)&nbsp;as soon as they are available, copies of any reports and financial statements furnished to or filed with the Commission, the Financial Industry Regulatory Authority or any national securities exchange on which any class of securities of the
Company is listed; and (ii)&nbsp;such additional information concerning the business and financial condition of the Company as the Underwriters may from time to time reasonably request; <I>provided</I> that the Company shall not be required to
provide documents the provision of which would require public disclosure by the Company under Regulation FD; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(j) </B>To use the net proceeds received by it from the sale of the Securities pursuant to this Agreement
in the manner specified in the Prospectus under the caption &#147;Use of Proceeds&#148;; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(k) </B>Not to take, directly or indirectly, any action
designed to or which would reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(l) </B>Other than as contemplated by this Agreement, not to incur any liability for any finder&#146;s or broker&#146;s fee or agent&#146;s commission in
connection with the execution and delivery of this Agreement or the consummation of the transactions contemplated hereby; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(m) </B>During the
Prospectus Delivery Period, to file with the Commission such periodic and special reports as required by the Rules&nbsp;and Regulations; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(n) </B>To
maintain the controls and other procedures required by Sections 302 and 906 of the Sarbanes-Oxley Act and the applicable regulations thereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(o)
</B>Upon request of any Underwriter, to furnish, or cause to be furnished, to such Underwriter an electronic version of the Company&#146;s trademarks, servicemarks and corporate logo for use on the website, if any, operated by such Underwriter for
the purpose of facilitating the <FONT STYLE="white-space:nowrap">on-line</FONT> offering of the Securities (the &#147;<B><I>License</I></B>&#148;); <I>provided</I>, <I>however</I>, that the License shall be used solely for the purpose described
above, is granted without any fee and may not be assigned or transferred; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(p) </B>To comply with all applicable provisions of the Sarbanes-Oxley Act;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(q) </B>If the Company elects to rely upon Rule 462(b) under the Securities Act, to file a Rule 462(b) Registration Statement with the Commission in
compliance with Rule 462(b) under the Securities Act by 10:00 p.m., Washington, D.C. time, on the date of this Agreement, and, at the time of filing, either to pay to the Commission the filing fee for the Rule 462(b) Registration Statement or give
irrevocable instructions for the payment of such fee pursuant to Rule 111(b) under the Securities Act; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(r) </B>To use its reasonable best efforts
to list the Shares and Warrant Shares on the Nasdaq Capital Market and to maintain the listing of the Shares and Warrant Shares on the Nasdaq Capital Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. (a) </B>The Company represents and agrees that, without the prior consent of the Representative, it has not made and will not make any offer relating to
the Securities that would constitute a &#147;free writing prospectus&#148; as defined in Rule 405 under the Securities Act; each Underwriter represents and agrees that, without the prior consent of the Company and the Representative, it has not made
and will not make any offer relating to the Securities that would constitute a free writing prospectus; any such free writing prospectus the use of which has been consented to by the Company and the Representative is listed on
<U>Schedule</U><U></U><U>&nbsp;II</U> hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b) </B>The Company has complied and will comply with the requirements of Rule&nbsp;433 under the
Securities Act applicable to any Issuer Free Writing Prospectus, including, without limitation, timely filing with the Commission or retention where required and legending; and the Company represents that it has satisfied and agrees that it will
satisfy the conditions under Rule&nbsp;433 under the Securities Act to avoid a requirement to file with the Commission any electronic road show. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(c)
</B>The Company agrees that if at any time following issuance of an Issuer Free Writing Prospectus any event occurred or occurs as a result of which such Issuer Free Writing Prospectus would conflict with the information in the Registration
Statement, the Disclosure Package or the Prospectus or would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances then prevailing, not
misleading, the Company will give prompt notice thereof to the Representative and, if requested by the Representative, will prepare and furnish without charge to the Representative an Issuer Free Writing Prospectus or other document that will
correct such conflict, statement or omission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. </B>The Company covenants and agrees with the several Underwriters that the Company will pay or cause
to be paid the following, whether or not the transactions contemplated hereunder are consummated or this Agreement is prevented from becoming effective or is terminated: (a)&nbsp;all expenses (including, without limitation, transfer taxes allocated
to the respective transferees) incurred by the Company in connection with the delivery to the Underwriters of the Securities; (b)&nbsp;all expenses (including, without limitation, the fees, disbursements and expenses of the Company&#146;s counsel
and accountants) incurred by the Company in connection with the preparation, printing, reproduction, filing, delivery and shipping of the Registration Statement, the Preliminary Prospectus, any Issuer Free Writing Prospectus, the Disclosure Package
and the Prospectus, and amendments and supplements thereto, and the mailing and delivery of copies thereof to the Underwriters and dealers; (c)&nbsp;the cost of printing, delivery and shipping of this Agreement, closing documents (including, without
limitation, any compilations thereof) and any other documents in connection with the offering, purchase, sale and delivery of the Securities; (d)&nbsp;all expenses in connection with the qualification of the Securities for offering and sale under
state securities laws as provided in Section&nbsp;6(c) hereof; (e)&nbsp;all fees and expenses in connection with listing the Shares and Warrant Shares on the Nasdaq Capital Market; (f)&nbsp;the cost of preparing stock certificates; (g)&nbsp;the cost
and charges of any transfer agent or registrar; (h)&nbsp;the costs and expenses of the Company relating to investor presentations or any &#147;roadshow&#148; undertaken in connection with the marketing of the Securities, provided that the
Underwriters will pay all of the travel, lodging and other expenses of the Underwriters or any of their employees incurred by them in connection with the &#147;roadshow;&#148; and (i)&nbsp;all other costs and expenses incident to the performance of
the Company&#146;s obligations hereunder which are not otherwise specifically provided for in this Section&nbsp;8 and (j)&nbsp;the fees and expenses of counsel to the Underwriters in an amount not to exceed $75,000 in the aggregate; provided that,
except as provided in this Section&nbsp;8 and in Section&nbsp;14, the Underwriters shall pay their own costs and expenses, including the costs and expenses of their counsel, any transfer taxes on the Securities which they may sell and the expenses
of advertising any offering of the Securities made by the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. </B>The obligations of the Underwriters hereunder, as to the Securities to
be delivered at the applicable Time of Delivery, shall be subject, in the Underwriters&#146; discretion, to the condition that all representations and warranties and other statements of the Company herein are, at and as of such Time of Delivery,
true and correct, the condition that the Company shall have performed all of its obligations hereunder theretofore to be performed, and the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(a) </B>If filing of the Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus, is required under the Securities Act or
the Rules&nbsp;and Regulations, the Company shall have filed the Prospectus (or such amendment or supplement) or such Issuer Free Writing Prospectus with the Commission in the manner and within the time period so required (without reliance on
Rule&nbsp;424(b)(8)&nbsp;or Rule&nbsp;164(b)); the Registration Statement shall remain effective; no stop order suspending the effectiveness of the Registration Statement or any part thereof or any amendment thereto shall have been issued and no
proceeding for that purpose shall have been initiated or threatened by the Commission; no stop order suspending or preventing the use of the Disclosure Package, the Prospectus or any Issuer Free Writing Prospectus shall have been issued and no
proceeding for that purpose shall have been initiated or threatened by the Commission; and all requests for additional information on the part of the Commission shall have been complied with to the Representative&#146;s reasonable satisfaction; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b) </B>The Underwriters shall not have advised the Company that (i)&nbsp;the Registration Statement or any amendment thereof or supplement thereto
contains an untrue statement of a material fact which, in the opinion of the Underwriters, is material or omits to state a material fact which, in the opinion of the Underwriters, is required to be stated therein or necessary to make the statements
therein not misleading; or (ii)&nbsp;the Disclosure Package or the Prospectus, or any amendment thereof or supplement thereto, or any Issuer Free Writing Prospectus contains an untrue statement of fact which, in the opinion of the Underwriters, is
material, or omits to state a fact which, in the opinion of the Underwriters, is material and is required to be stated therein, or necessary to make the statements therein, in light of the circumstances under which they are made, not misleading;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(c) </B>Goodwin Procter LLP, counsel for the Underwriters, shall have furnished to the Underwriters an opinion and written statement, dated the
applicable Time of Delivery, and such counsel shall have received such papers and information as they request to enable them to pass upon such matters; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d) </B>Morgan, Lewis&nbsp;&amp; Bockius LLP, counsel for the Company, shall have furnished to the
Underwriters an opinion and written statement, dated the applicable Time of Delivery, in form and substance reasonably satisfactory to the Representative; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(e) </B>Hamilton, Brook, Smith&nbsp;&amp; Reynolds, P.C., Intellectual Property counsel for the Company, shall have furnished to the Underwriters an
opinion and written statement, dated the applicable Time of Delivery, in form and substance reasonably satisfactory to the Representative; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(f) </B>On
the date of this Agreement and at the applicable Time of Delivery, RSM US LLP shall have furnished to the Underwriters a letter or letters, dated the respective dates of delivery thereof, in form and substance reasonably satisfactory to the
Representative, containing statements and information of the type ordinarily included in accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the financial statements audited or reviewed by RSM US LLP, and certain other
financial information contained or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(g) </B>The
Company or any of its Subsidiaries shall not have sustained since the date of the latest audited financial statements included in the Prospectus any loss or interference with their business from fire, explosion, flood or other calamity, whether or
not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth or contemplated in the Prospectus; and (ii)&nbsp;since the respective dates as of which information is given in the
Disclosure Package, the Company or any of its Subsidiaries shall not have incurred any material liabilities or obligations, direct or contingent, entered into any material transactions or declared or paid any dividends or made any distribution of
any kind with respect to the Company&#146;s capital stock; there shall not have been any change in the capital stock or short-term or long-term debt of the Company; there shall not have been any issuance of options, warrants, convertible securities
or other rights to purchase capital stock of the Company (in each case, other than as a result of the grant or exercise of stock options, the offer to sell shares of stock and award shares of restricted stock, stock units or performance
shares/performance units under the Company&#146;s existing equity incentive plans or the repurchase of shares of capital stock pursuant to agreements providing for an option to repurchase or a right of first refusal on behalf of the Company); and
there shall not have been any change in or affecting the business, prospects, operations, assets, condition (financial or otherwise) or results of operations of the Company, otherwise than as set forth or contemplated in the Disclosure Package and
the Prospectus, the effect of which, in any such case described in clause&nbsp;(i) or (ii), is in the judgment of the Representative so material and adverse as to make it impracticable or inadvisable to proceed with the public offering or the
delivery of the Securities being delivered at the applicable Time of Delivery on the terms and in the manner contemplated in the Disclosure Package and the Prospectus; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(h) </B>On or after the Applicable Time there shall not have occurred any of the following: (i)&nbsp;a suspension or material limitation in trading in
securities generally on the New York Stock Exchange, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market or the NYSE American; (ii)&nbsp;a suspension or material limitation in trading in the Company&#146;s securities
on the Nasdaq Capital Market; (iii)&nbsp;a general moratorium on commercial banking activities declared by either Federal or New York State authorities or a material disruption in commercial banking or securities settlement or clearance services in
the United States; (iv)&nbsp;the outbreak or escalation of hostilities involving the United States or the declaration by the United States of a national emergency or war; or (v)&nbsp;the occurrence of any other calamity or crisis or any change in
financial, political or economic conditions in the United States or elsewhere, if the effect of any such event specified in clause&nbsp;(iv) or (v)&nbsp;in the Representative&#146;s judgment makes it impracticable or inadvisable to proceed with the
public offering or the delivery of the Securities being delivered at the applicable Time of Delivery on the terms and in the manner contemplated in the Disclosure Package or the Prospectus; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(i) </B>The Shares and Warrant Shares to be sold at the applicable Time of Delivery shall have been approved for listing on the Nasdaq Capital Market; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(j) </B>The Company has obtained and delivered to the Underwriters executed copies of <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements from the
executive officers and directors of the Company and certain other persons listed on <U>Schedule</U><U></U><U>&nbsp;IV</U> hereto, substantially to the effect set forth in <U>Exhibit</U><U></U><U>&nbsp;B</U> hereto, except to the extent waived by the
Representative; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(k) </B>The Company shall have complied with the provisions of Section&nbsp;6(d) hereof with respect to
the furnishing of prospectuses on the New York Business Day next succeeding the date of this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(l) </B>The Company shall have furnished or
caused to be furnished to the Underwriters at the applicable Time of Delivery certificates of the chief executive officer and the chief financial officer of the Company, on behalf of the Company and not in their individual capacities, reasonably
satisfactory to the Underwriters as to the accuracy of the representations and warranties of the Company herein at and as of such Time of Delivery, as to the performance by the Company of all of its respective obligations hereunder to be performed
at or prior to such Time of Delivery, and as to such other matters as the Underwriters may reasonably request, and the Company shall have furnished or caused to be furnished certificates as to the matters set forth in subsections&nbsp;(a) and
(g)&nbsp;of this Section; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(m) </B>The Underwriters shall have received at the applicable Time of Delivery a certificate of the Chief Financial Officer
of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(n) </B>The Underwriters shall have received at the applicable Time of Delivery a certificate of the Secretary of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(o) </B>The Company shall have furnished to the Underwriters such additional documents, certificates and evidence as the Underwriters may have reasonably
requested to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions, herein contained, or otherwise in connection with the offering of the Securities contemplated hereby; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(p) </B>The Company shall, at all times while the Company is subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act and any
Warrants are outstanding, use its best efforts to maintain a registration statement covering the exercise of the Warrants and the issue and sale of the Warrant Shares such that the Warrant Shares, when issued, will not be subject to resale
restrictions under the Securities Act except to the extent that the Warrant Shares are owned by affiliates; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(q) </B>The Company shall, at all
times while any Warrants are outstanding, reserve and keep available out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise of such
warrants, the number of Warrant Shares that are initially issuable and deliverable upon the exercise of the then-outstanding Warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as
otherwise stated herein, all such opinions, certificates, letters and other documents mentioned above and elsewhere in this Agreement will be in compliance with the provisions hereof only if they are reasonably satisfactory in form and substance to
the Underwriters and their counsel. The Company will furnish the Underwriters with such conformed copies of such opinions, certificates, letters and other documents as the Underwriters shall reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. (a) </B>The Company will indemnify and hold harmless each Underwriter from and against any losses, claims, damages or liabilities, joint or several, to
which such Underwriter may become subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement
of a material fact contained in the Registration Statement, including the Rule 430B Information and any other information deemed to be part of the Registration Statement at the time of effectiveness and at any subsequent time pursuant to the Rules
and Regulations, if applicable, any Preliminary Prospectus, the Disclosure Package or the Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus, or arise out of or are based upon the omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse each Underwriter for any legal or other expenses reasonably incurred by such Underwriter in connection with
investigating or defending any such action or claim as such expenses are incurred; provided, however, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon
an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, the Disclosure Package or the Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus, in reliance
upon and in conformity with information furnished in writing to the Company by or on behalf of any Underwriter through the Representative expressly for use therein; it being understood and agreed that the only such information furnished by or on
behalf of any Underwriter through the Representative consists of the information described as such in Section&nbsp;10(f); and will reimburse the Underwriters for any legal or other expenses reasonably incurred by the Underwriters in connection with
investigating or defending any such action or claim as such expenses are incurred. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b) </B>Each Underwriter, severally and not jointly, will indemnify and hold harmless the Company against
any losses, claims, damages or liabilities to which the Company may become subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an
untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, any Preliminary Prospectus, the Disclosure Package, the Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing
Prospectus, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the
extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement, any Preliminary Prospectus, the Disclosure Package, the Prospectus, or any amendment or supplement thereto, or any
Issuer Free Writing Prospectus, in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of any Underwriter through the Representative expressly for use therein; it being understood and agreed that the
only such information furnished by or on behalf of any Underwriter through the Representative consists of information described as such in Section&nbsp;10(f); and will reimburse the Company for any legal or other expenses reasonably incurred by the
Company in connection with investigating or defending any such action or claim as such expenses are incurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(c) </B>Promptly after receipt by an
indemnified party under subsection&nbsp;(a) or (b)&nbsp;above of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the
indemnifying party in writing of the commencement thereof; but the omission so to notify the indemnifying party shall not relieve it from any liability which it may have to any indemnified party except to the extent that such indemnifying party has
been materially prejudiced by such failure. In case any such action shall be brought against any indemnified party and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate
therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party (who shall not, except with the consent of the
indemnified party, be counsel to the indemnifying party), and, after notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party
under such subsection for any legal expenses of other counsel or any other expenses, in each case subsequently incurred by such indemnified party, in connection with the defense thereof other than reasonable costs of investigation. No indemnifying
party shall, without the written consent of the indemnified party, effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened action or claim in respect of which indemnification or
contribution may be sought hereunder (whether or not the indemnified party is an actual or potential party to such action or claim) unless such settlement, compromise or judgment (i)&nbsp;includes an unconditional release of the indemnified party
from all liability arising out of such action or claim; and (ii)&nbsp;does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d) </B>If the indemnification provided for in this Section&nbsp;10 is unavailable to or insufficient to hold harmless an indemnified party under
subsection (a)&nbsp;or (b)&nbsp;above in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to therein, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party
as a result of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other from the
offering of the Securities. If, however, the allocation provided by the immediately preceding sentence is not permitted by applicable law or if the indemnified party failed to give the notice required under subsection (c)&nbsp;above, then each
indemnifying party shall contribute to such amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company on the one hand and the
Underwriters on the other in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations. The relative benefits
received by the Company on the one hand and the Underwriters on the other shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the Company bear to the total underwriting
discounts and commissions received by the Underwriters, in each case as set forth in the table on the cover page of the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a
material fact relates to information supplied by the Company on the one hand or the Underwriters on the other and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant to this subsection (d)&nbsp;were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by
any other method of allocation which does not take account of the equitable considerations referred to above in this subsection (d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or
actions in respect thereof) referred to above in this subsection (d)&nbsp;shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of this subsection (d), no Underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the Securities underwritten by it and distributed to the public were offered
to the public exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within
the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&#146; obligations in this subsection (d)&nbsp;to contribute are
several in proportion to their respective underwriting obligations and not joint. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(e) </B>The obligations of the Company under this Section&nbsp;10
shall be in addition to any liability which the Company may otherwise have and shall extend, upon the same terms and conditions, to each person, if any, who controls any Underwriter within the meaning of the Securities Act; and the obligations of
any Underwriter under this Section&nbsp;10 shall be in addition to any liability which the respective Underwriters may otherwise have and shall extend, upon the same terms and conditions, to each director of the Company (including any person who,
with his or her consent, is named in the Registration Statement as about to become a director of the Company), to each officer of the Company who has signed the Registration Statement and to each person, if any, who controls the Company within the
meaning of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(f) </B>Each Underwriter confirms and the Company acknowledges that the statements with respect to the public offering
of the Securities by the Underwriters set forth in the following paragraphs under the caption &#147;Underwriting&#148; in the Prospectus: (i)&nbsp;the first paragraph under &#147;Discounts and Commissions&#148; and (ii)&nbsp;the paragraphs under
&#147;Stabilization&#148;, constitute the only information concerning the Underwriters furnished in writing to the Company by or on behalf of any Underwriter through the Representative expressly for use in the Registration Statement, any Preliminary
Prospectus, the Disclosure Package, the Prospectus or any Issuer Free Writing Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. </B>The Underwriters shall have the right to terminate
this Agreement (or the obligations of the several Underwriters with respect to any Option Shares which have yet to be purchased) by giving notice to the Company as hereinafter specified at any time at or prior to the applicable Time of Delivery, if
(a)&nbsp;any condition of the Underwriters&#146; obligations hereunder is not fulfilled; (b)&nbsp;trading on the New York Stock Exchange, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market or the NYSE American shall
have been suspended; (c)&nbsp;a banking moratorium shall have been declared by federal or state authorities; or (d)&nbsp;there shall have occurred any outbreak or escalation of hostilities, any change in financial markets or any calamity or crisis
that, in the Representative&#146;s judgment, is material and adverse and makes it impractical or inadvisable to proceed with the completion of the sale of and payment for the Firm Shares and the Warrants or the Option Shares, as the case may be. Any
such termination shall be without liability of any party to any other party except that the provisions of Section&nbsp;8 and Section&nbsp;10 hereof shall at all times be effective and shall survive such termination. If the Underwriters elect to
terminate this Agreement as provided in this Section&nbsp;11, the Company shall be notified promptly by the Underwriters by telephone, confirmed by letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. (a) </B>If any Underwriter shall default in its obligation to purchase the Securities which it has agreed to purchase hereunder at the applicable Time
of Delivery, the Representative may in its sole discretion arrange for another party or other parties to purchase such Securities on the terms contained herein. If within <FONT STYLE="white-space:nowrap">thirty-six</FONT> hours after such default by
any Underwriter the Representative do not arrange for the purchase of such Securities, then the Company shall be entitled to a further period of <FONT STYLE="white-space:nowrap">thirty-six</FONT> hours within which to procure another party or other
parties reasonably satisfactory to the Representative to purchase such Securities on such terms. In the event that, within the respective prescribed periods, the Representative notifies the Company that the Representative has so arranged for the
purchase </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of such Securities, or the Company notifies the Representative that the Company has so arranged for the purchase of such Securities, the Representative or the Company shall have the right to
postpone the applicable Time of Delivery for a period of not more than seven days, in order to effect whatever changes may thereby be made necessary in the Registration Statement, the Disclosure Package or the Prospectus, or in any other documents
or arrangements, and the Company agrees to file promptly any amendments or supplements to the Registration Statement, the Disclosure Package or the Prospectus which in the Representative&#146;s opinion may thereby be made necessary. The term
&#147;<B><I>Underwriter</I></B>&#148; as used in this Agreement shall include any person substituted under this Section with like effect as if such person had originally been a party to this Agreement with respect to such Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b) </B>If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the Representative
and the Company as provided in subsection (a)&nbsp;above, the aggregate number of such Securities which remain unpurchased does not exceed <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate number of all the Securities to be
purchased at the applicable Time of Delivery, then the Company shall have the right to require each <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase the number of Securities which such Underwriter agreed to purchase
hereunder at the applicable Time of Delivery and, in addition, to require each <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase its pro rata share (based on the number of Securities which such Underwriter agreed to
purchase hereunder) of the Securities of such defaulting Underwriter or Underwriters for which such arrangements have not been made; but nothing herein shall relieve a defaulting Underwriter from liability for its default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(c) </B>If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the Representative
and the Company as provided in subsection (a)&nbsp;above, the aggregate number of such Securities which remains unpurchased exceeds <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate number of all of the Securities to be purchased
at the applicable Time of Delivery (other than by reason of any default on the part of the Company), or if the Company shall not exercise the right described in subsection (b)&nbsp;above to require
<FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters to purchase Securities of a defaulting Underwriter or Underwriters, then the Company will have the right, by written notice given within the following
<FONT STYLE="white-space:nowrap">36-hour</FONT> period to the Representative, to terminate this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. </B>The respective indemnities,
agreements, representations, warranties and other statements of the Company and the several Underwriters, as set forth in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement, shall remain in full force and
effect, regardless of any investigation (or any statement as to the results thereof) made by or on behalf of any Underwriter or any controlling person of any Underwriter, or the Company or any officer or director or controlling person of the
Company, and shall survive delivery of and payment for the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. </B>If this Agreement shall be terminated pursuant to Section&nbsp;12(c)
hereof, the Company shall not then be under any liability to any Underwriter except as provided in Sections 8 and 10 hereof; but, except as otherwise provided in this Agreement, if for any other reason any Securities are not delivered by or on
behalf of the Company as provided herein, the Company will reimburse the Underwriters for all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses, including, without limitation, fees and
disbursements of counsel, reasonably incurred by the Underwriters in making preparations for the purchase, sale and delivery of the Securities not so delivered, but the Company shall then be under no further liability to any Underwriter in respect
of the Securities not so delivered, except as provided in Sections&nbsp;8 and 10 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. </B>All statements, requests, notices and agreements
hereunder shall be in writing, and if to the Underwriters shall be delivered or sent by mail, electronic or facsimile transmission to the Representative as follows: Stifel, Nicolaus&nbsp;&amp; Company, Incorporated, 787 Seventh Avenue, New York, New
York 10019, Attention: General Counsel, with a copy to Goodwin Procter LLP, 620 Eighth Ave., New York, New York 10018, Attention: Thomas Levato, Esq.; and if to the Company shall be delivered or sent by mail, electronic or facsimile transmission as
follows: Kopin Corporation, 125 North Drive, Westborough, Massachusetts 01581, Attention: Chief Financial Officer, with a copy to Morgan, Lewis&nbsp;&amp; Bockius LLP, One Federal Street, Boston, Massachusetts 02110, Attention: John J. Concannon
III. Any such statements, requests, notices or agreements shall take effect upon receipt thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. </B>In all dealings hereunder, the
Representative shall act on behalf of each of the Underwriters, and the parties hereto shall be entitled to act and rely upon any statement, request, notice or agreement on behalf of any Underwriter made or given by the Representative. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. </B>This Agreement shall be binding upon, and inure solely to the benefit of, the Underwriters and
the Company and, to the extent provided in Sections&nbsp;10 and 13 hereof, the officers and directors of the Company and each person who controls the Company, each person who controls any Underwriter, and their respective heirs, executors,
administrators, successors and assigns, and no other person shall acquire or have any right under or by virtue of this Agreement. No purchaser of any of the Securities from any Underwriter shall be deemed a successor or assign by reason merely of
such purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>18. </B>Time shall be of the essence of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>19. </B>This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein (express or implied) may be
waived unless waived in writing by each party whom the condition is meant to benefit. The section headings herein are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>20. This Agreement shall be governed by and construed in accordance with the laws of the State of New York. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>21. </B>This Agreement may be executed by any one or more of the parties hereto in any number of counterparts, each of which shall be deemed to be an
original, but all such counterparts shall together constitute one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>22. </B>Notwithstanding anything herein to the contrary,
the Company is authorized to disclose to any persons the U.S. federal and state income tax treatment and tax structure of the potential transaction contemplated by this Agreement and all materials of any kind (including, without limitation, tax
opinions and other tax analyses) provided to the Company relating to that treatment and structure, without the Underwriters imposing any limitation of any kind. However, any information relating to the tax treatment and tax structure shall remain
confidential (and the foregoing sentence shall not apply) to the extent necessary to enable any person to comply with securities laws. For this purpose, &#147;tax structure&#148; is limited to any facts that may be relevant to that treatment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please sign and return to us one for the Company plus one for counsel of any counterparts hereof,
and upon the acceptance hereof by the Underwriters, this Agreement and such acceptance hereof shall constitute a binding agreement between the Underwriters and the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>23. (a) </B>In the event that any Underwriter is a Covered Entity and becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer
from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such
interest and obligation, were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b)</B> In the event that any Underwriter is
a Covered Entity or a BHC Act Affiliate of such Underwriter and becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised
to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;23: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B><I>BHC Act
Affiliate</I></B>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Covered Entity</I></B>&#148; means any of the following: (i)&nbsp;a &#147;covered entity&#148; as that term is defined in, and interpreted in
accordance with, 12 C.F.R. &#167; 252.82(b); (ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;47.3(b); or (iii)&nbsp;a &#147;covered FSI&#148; as that term is defined in, and interpreted
in accordance with, 12 C.F.R. &#167;382.2(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Default Right</I></B>&#148; has the meaning assigned to that term in, and shall be interpreted
in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B><I>U.S. Special Resolution Regime</I></B>&#148; means each of (i)&nbsp;the Federal Deposit
Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">KOPIN CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Richard Sneider</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Richard Sneider</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Chief Financial Officer</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted as of the date hereof</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">STIFEL, NICOLAUS&nbsp;&amp; COMPANY, INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Cole Bader</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Cole Bader</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For and as Representative of the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">other Underwriters named in <U>Schedule I</U> hereto </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE I </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNDERWRITERS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Number&nbsp;of<BR>Firm Shares<BR>to&nbsp;be&nbsp;Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Number&nbsp;of<BR><FONT STYLE="white-space:nowrap">Pre-Funded</FONT><BR>Warrants to be<BR>Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stifel, Nicolaus&nbsp;&amp; Company, Incorporated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE II </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ISSUER FREE WRITING PROSPECTUSES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None.
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE III </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRICING INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Public Offering Price
Per Share: $1.00 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Public Offering Price Per <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrant: $0.99 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of Firm Shares Offered: 14,000,000 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants to Purchase a Total of 6,000,000 Shares of Common Stock </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Underwriting Discount: 6% </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Firm Shares Time of Delivery: January&nbsp;27, 2023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other
Material Terms of the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Exercise Price: $0.01 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Exercise Term: Indefinite </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE IV </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE OFFICERS, DIRECTORS AND OTHER PERSONS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTING LOCKUP AGREEMENTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael
Murray </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">John C.C. Fan </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James K. Brewington </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chi Chia Hsieh </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scott L. Anchin </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Richard A. Sneider </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hong Choi </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Paul Baker </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jill Avery </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>d432826dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KOPIN CORPORATION </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM
OF WARRANT TO PURCHASE COMMON STOCK </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Number of Shares: [&#149;] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">(subject to adjustment) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant No. [&#149;]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">Original Issue Date: January [&#149;], 2023</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kopin Corporation, a Delaware corporation (the &#147;<B>Company</B>&#148;), hereby certifies that, for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, [&#149;] or its registered assigns (the &#147;<B>Holder</B>&#148;) is entitled, subject to the terms set forth below, to purchase from the Company up to a total of [&#149;]
shares of Common Stock, par value $0.01 (the &#147;<B>Common Stock</B>&#148;), of the Company (each such share, a &#147;<B>Warrant Share</B>&#148; and all such shares, the &#147;<B>Warrant Shares</B>&#148;) at an exercise price per share equal to
$0.01 per share (as adjusted from time to time as provided in <U>Section</U><U></U><U>&nbsp;9</U> herein, the &#147;<B>Exercise Price</B>&#148;) upon surrender of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock
issued in exchange, transfer or replacement hereof, the &#147;<B>Warrant</B>&#148;) at any time and from time to time on or after the date hereof (the &#147;<B>Original Issue Date</B>&#148;), subject to the following terms and conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <I>Definitions</I>. For purposes of this Warrant, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) &#147;<B>Affiliate</B>&#148; means any Person directly or indirectly controlled by, controlling or under common control with, a Holder, as
such terms are used in and construed under Rule 405 under the Securities Act, but only for so long as such control shall continue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
&#147;<B>Commission</B>&#148; means the United States Securities and Exchange Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) &#147;<B>Closing Sale Price</B>&#148;
means, for any security as of any date, the last trade price for such security on the Principal Trading Market for such security as reported by Bloomberg L.P. or, if such Principal Trading Market begins to operate on an extended hours basis and does
not designate the last trade price, then the last trade price of such security prior to 4:00 P.M., New York City time, as reported by Bloomberg L.P., or if the security is not listed for trading on a national securities exchange or other trading
market on the relevant date, the last quoted bid price for the security in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market on the relevant date as reported by OTC Markets Group Inc. (or a
similar organization or agency succeeding to its functions of reporting prices). If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date
shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then the Board of Directors of the Company shall use its good faith
judgment to determine the fair market value. The Board of Directors&#146; determination shall be binding upon all parties absent demonstrable error. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock
combination or other similar transaction during the applicable calculation period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) &#147;<B>Principal Trading Market</B>&#148; means
the national securities exchange or other trading market on which the Common Stock is primarily listed on and quoted for trading, which, as of the Original Issue Date, shall be the Nasdaq Global Select Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) &#147;<B>Registration Statement</B>&#148; means the Company&#146;s Registration Statement on Form
<FONT STYLE="white-space:nowrap">S-3</FONT> (File No.&nbsp;333- 253933), declared effective on April&nbsp;27, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)
&#147;<B>Securities Act</B>&#148; means the Securities Act of 1933, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) &#147;<B>Trading Day</B>&#148; means any weekday on
which the Principal Trading Market is open for trading. If the Common Stock is not listed or admitted for trading, &#147;Trading Day&#148; means any day except any Saturday, any Sunday, any day that is a federal legal holiday in the United States or
any day on which banking institutions in New York City are authorized or required by law or other governmental action to close. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) &#147;<B>Transfer Agent</B>&#148; means Computershare Trust Company, N.A., the
Company&#146;s transfer agent and registrar for the Common Stock, and any successor appointed in such capacity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <I>Issuance of Securities;
Registration of Warrants</I>. The Warrant, as initially issued by the Company, is offered and sold pursuant to the Registration Statement. As of the Original Issue Date, the Warrant Shares are issuable under the Registration Statement. Accordingly,
the Warrant and, assuming issuance pursuant to the Registration Statement or an exchange meeting the requirements of Section&nbsp;3(a)(9) of the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;), as in effect on the
Original Issue Date, the Warrant Shares are not &#147;restricted securities&#148; under Rule 144 promulgated under the Securities Act. The Company shall register ownership of this Warrant, upon records to be maintained by the Company for that
purpose (the &#147;<B>Warrant Register</B>&#148;), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any assignee to which this Warrant is assigned hereunder) from time to time. The Company may deem and
treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder and for all other purposes, absent actual notice to the contrary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <I>Registration of Transfers</I>. Subject to compliance with all applicable securities laws, the Company shall, or will cause its Transfer Agent to,
register the transfer of all or any portion of this Warrant in the Warrant Register upon surrender of this Warrant and payment for all applicable transfer taxes (if any). Upon any such registration or transfer, a new warrant to purchase Common Stock
in substantially the form of this Warrant (any such new warrant, a &#147;<B>New Warrant</B>&#148;) evidencing the portion of this Warrant so transferred shall be issued to the transferee, and a New Warrant evidencing the remaining portion of this
Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations in respect of the New
Warrant that the Holder has in respect of this Warrant. The Company shall, or will cause its Transfer Agent to, prepare, issue and deliver at the Company&#146;s own expense any New Warrant under this <U>Section</U><U></U><U>&nbsp;3</U>. Until due
presentment for registration of transfer, the Company may treat the registered Holder hereof as the owner and holder for all purposes, and the Company shall not be affected by any notice to the contrary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <I>Exercise and Duration of Warrants</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) All or any part of this Warrant shall be exercisable by the registered Holder in any manner permitted by this Warrant at any time and from
time to time on or after the Original Issue Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Holder may exercise this Warrant by delivering to the Company (i)&nbsp;an
exercise notice in the form attached as <U>Schedule 1</U> hereto (the &#147;<B>Exercise Notice</B>&#148;), completed and duly signed, and (ii)&nbsp;payment of the Exercise Price for the number of Warrant Shares as to which this Warrant is being
exercised (which may take the form of a &#147;cashless exercise&#148; if so indicated in the Exercise Notice pursuant to <U>Section</U><U></U><U>&nbsp;10</U> below). The date on which such exercise notice is delivered to the Company (as determined
in accordance with the notice provisions hereof) is an <B>&#147;Exercise Date</B>.&#148; The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice shall
have the same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining number of Warrant Shares, if any. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on
the face hereof.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <I>Delivery of Warrant Shares</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Upon exercise of this Warrant, the Company shall promptly (but in no event later than three (3)&nbsp;Trading Days after the Exercise
Date), upon the request of the Holder, credit such aggregate number of shares of Common Stock to which the Holder is entitled pursuant to such exercise to the Holder&#146;s or its designee&#146;s balance account with The Depository Trust Company
(&#147;<B>DTC</B>&#148;) through its Deposit Withdrawal Agent Commission system, or if the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Transfer Agent is not participating in the Fast Automated Securities Transfer Program (the &#147;<B>FAST Program</B>&#148;) or if the certificates are required to bear a legend regarding
restriction on transferability, issue and dispatch by overnight courier to the address as specified in the Exercise Notice, a certificate, registered in the Company&#146;s share register in the name of the Holder or its designee, for the number of
shares of Common Stock to which the Holder is entitled pursuant to such exercise. The Holder, or any natural person or legal entity (each, a &#147;<B>Person</B>&#148;) so designated by the Holder to receive Warrant Shares, shall be deemed to have
become the holder of record of such Warrant Shares as of the Exercise Date, irrespective of the date such Warrant Shares are credited to the Holder&#146;s DTC account or the date of delivery of the certificates evidencing such Warrant Shares, as the
case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If by the close of the third (3rd) Trading Day after the Exercise Date, the Company fails to deliver to the Holder a
certificate representing the required number of Warrant Shares in the manner required pursuant to <U>Section</U><U></U><U>&nbsp;5(a)</U> or fails to credit the Holder&#146;s DTC account for such number of Warrant Shares to which the Holder is
entitled, and if after such third (3rd) Trading Day and prior to the receipt of such Warrant Shares, the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of the
Warrant Shares that the Holder anticipated receiving upon such exercise (a &#147;<B><FONT STYLE="white-space:nowrap">Buy-In</FONT></B>&#148;), then the Company shall, within three (3)&nbsp;Trading Days after the Holder&#146;s written request and in
the Holder&#146;s sole discretion, either (i)&nbsp;pay in cash to the Holder an amount equal to the Holder&#146;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased, at which point the
Company&#146;s obligation to deliver such certificate (and to issue such Warrant Shares) shall terminate or (ii)&nbsp;promptly honor its obligation to deliver to the Holder a certificate or certificates representing such Warrant Shares and pay cash
to the Holder in an amount equal to the excess (if any) of Holder&#146;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased in the <FONT STYLE="white-space:nowrap">Buy-In</FONT> over the
product of (A)&nbsp;the number of shares of Common Stock purchased in the <FONT STYLE="white-space:nowrap">Buy-In,</FONT> times (B)&nbsp;the Closing Sale Price of a share of Common Stock on the Exercise Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) To the extent permitted by law and except to the extent the Company has fully performed its obligations under the provisions of
<U>Section</U><U></U><U>&nbsp;5(b)</U> with respect to a particular delivery failure thereunder, the Company&#146;s obligations to issue and deliver Warrant Shares in accordance with and subject to the terms hereof (including the limitations set
forth in <U>Section</U><U></U><U>&nbsp;11</U> below) are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment
against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged
violation of law by the Holder or any other Person, and irrespective of any other circumstance that might otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Except to the extent the
Company has fully performed its obligations under the provisions of <U>Section</U><U></U><U>&nbsp;5(b)</U> with respect to a particular delivery failure, nothing herein shall limit the Holder&#146;s right to pursue any other remedies available to it
hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#146;s failure to timely deliver certificates representing shares of Common Stock upon exercise of
the Warrant as required pursuant to the terms hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <I>Charges, Taxes and Expenses</I>. Issuance and delivery of certificates for shares of Common
Stock upon exercise of this Warrant shall be made without charge to the Holder for any issue or transfer tax, transfer agent fee or other incidental tax or expense (excluding any applicable stamp duties) in respect of the issuance of such
certificates, all of which taxes and expenses shall be paid by the Company; <I>provided</I>, <I>however</I>, that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the registration of any
certificates for Warrant Shares or the Warrants in a name other than that of the Holder or an Affiliate thereof. The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or
receiving Warrant Shares upon exercise hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. <I>Replacement of Warrant</I>. If this Warrant is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt of evidence reasonably satisfactory to the Company of such loss,
theft or destruction (in such case) and, in each case, a customary and reasonable indemnity and surety bond, if requested by the Company. Applicants for a New Warrant under such circumstances shall also comply with such other reasonable regulations
and procedures and pay such other reasonable third-party costs as the Company may prescribe. If a New Warrant is requested as a result of a mutilation of this Warrant, then the Holder shall deliver such mutilated Warrant to the Company as a
condition precedent to the Company&#146;s obligation to issue the New Warrant. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. <I>Reservation of Warrant Shares</I>. The Company covenants that it will, at all times while this Warrant
is outstanding, reserve and keep available out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise of this Warrant as herein provided, the
number of Warrant Shares that are initially issuable and deliverable upon the exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the Holder (taking into account the adjustments
and restrictions of <U>Section</U><U></U><U>&nbsp;9</U>). The Company covenants that all Warrant Shares so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly
and validly authorized, issued and fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> The Company will take all such action as may be reasonably necessary to assure that such shares of Common Stock may be issued as provided
herein without violation of any applicable law or regulation, or of any requirements of any securities exchange or automated quotation system upon which the Common Stock may be listed. The Company further covenants that it will not, without the
prior written consent of the Holder, take any actions to increase the par value of the Common Stock at any time while this Warrant is outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.
<I>Certain Adjustments</I>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth in this <U>Section</U><U></U><U>&nbsp;9</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Stock Dividends and Splits</U>. If at any time while this Warrant is outstanding, the Company (i)&nbsp;pays a stock dividend on its
Common Stock or otherwise makes a distribution on any class of capital stock issued and outstanding on the Original Issue Date and in accordance with the terms of such stock on the Original Issue Date, as described in the Registration Statement,
that is payable in shares of Common Stock, (ii)&nbsp;subdivides its outstanding shares of Common Stock into a larger number of shares of Common Stock, (iii)&nbsp;combines its outstanding shares of Common Stock into a smaller number of shares of
Common Stock or (iv)&nbsp;issues by reclassification of shares of capital stock any additional shares of Common Stock of the Company, then in each such case the Exercise Price shall be multiplied by a fraction, the numerator of which shall be the
number of shares of Common Stock outstanding immediately before such event and the denominator of which shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i)&nbsp;of this
paragraph shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution, provided, however, that if such record date shall have been fixed and such dividend is not
fully paid on the date fixed therefor, the Exercise Price shall be recomputed accordingly as of the close of business on such record date and thereafter the Exercise Price shall be adjusted pursuant to this paragraph as of the time of actual payment
of such dividends. Any adjustment pursuant to clause (ii)&nbsp;or (iii)&nbsp;of this paragraph shall become effective immediately after the effective date of such subdivision or combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Pro Rata Distributions</U>. If at any time while this Warrant is outstanding, the Company distributes to all holders of Common Stock
for no consideration (i)&nbsp;evidences of its indebtedness, (ii)&nbsp;any security (other than a distribution of Common Stock covered by the preceding paragraph) (iii)&nbsp;rights or warrants to subscribe for or purchase any security, or
(iv)&nbsp;cash or any other asset (in each case, a &#147;<B>Distribution</B>&#148;), other than a reclassification as to which <U>Section</U><U></U><U>&nbsp;9(c)</U> applies, then in each such case, the Holder shall be entitled to participate in
such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof,
including without limitation, the ownership limitation set forth in <U>Section</U><U></U><U>&nbsp;11(a)</U> hereof) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which
the record holders of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder&#146;s right to participate in any such Distribution would result in the Holder exceeding the
ownership limitation set forth in <U>Section</U><U></U><U>&nbsp;11(a)</U> hereof, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any Common Stock as a result of such
Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until the earlier of (i)&nbsp;such time, if ever, as the delivery to such Holder of such portion would not result in the Holder
exceeding the ownership limitation set forth in <U>Section</U><U></U><U>&nbsp;11(a)</U> hereof and (ii)&nbsp;such time as the Holder has exercised this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Fundamental Transactions</U>. If at any time while this Warrant is outstanding, (i)&nbsp;the Company effects any merger or
consolidation of the Company with or into another Person, in which the Company is not the surviving entity and in which the stockholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly, at least
50% of the voting power of the surviving entity immediately after such merger or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">consolidation, (ii)&nbsp;the Company effects any sale to another Person of all or substantially all of its
assets in one transaction or a series of related transactions, (iii)&nbsp;pursuant to any tender offer or exchange offer (whether by the Company or another Person), holders of capital stock tender shares representing more than 50% of the voting
power of the capital stock of the Company and the Company or such other Person, as applicable, accepts such tender for payment, (iv)&nbsp;the Company consummates a stock purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, <FONT STYLE="white-space:nowrap">spin-off</FONT> or scheme of arrangement) with another Person whereby such other Person acquires more than the 50% of the voting power of the capital stock of the
Company (except for any such transaction in which the stockholders of the Company immediately prior to such transaction maintain, in substantially the same proportions, the voting power of such Person immediately after the transaction) or
(v)&nbsp;the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (other than as a result of a
subdivision or combination of shares of Common Stock covered by <U>Section</U><U></U><U>&nbsp;9(a)</U> above) (in any such case, a &#147;<B>Fundamental Transaction</B>&#148;), then following such Fundamental Transaction the Holder shall have the
right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such
Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant without regard to any limitations on exercise contained herein (the &#147;<B>Alternate Consideration</B>&#148;). The Company
shall not effect any Fundamental Transaction in which the Company is not the surviving entity or the Alternate Consideration includes securities of another Person unless (i)&nbsp;the Alternate Consideration is solely cash and the Company provides
for the simultaneous &#147;cashless exercise&#148; of this Warrant pursuant to <U>Section</U><U></U><U>&nbsp;10</U> below or (ii)&nbsp;prior to or simultaneously with the consummation thereof, any successor to the Company, surviving entity or other
Person (including any purchaser of assets of the Company) shall assume the obligation to deliver to the Holder such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and the other
obligations under this Warrant. The provisions of this paragraph (c)&nbsp;shall similarly apply to subsequent transactions analogous of a Fundamental Transaction type. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Number of Warrant Shares</U>. Simultaneously with any adjustment to the Exercise Price pursuant to <U>Section</U><U></U><U>&nbsp;9</U>
(including any adjustment to the Exercise Price that would have been effected but for the final sentence in this paragraph (d)), the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased
proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the increased or decreased number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.
Notwithstanding the foregoing, in no event may the Exercise Price be adjusted below the par value of the Common Stock then in effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)
<U>Calculations</U>. All calculations under this <U>Section</U><U></U><U>&nbsp;9</U> shall be made to the nearest <FONT STYLE="white-space:nowrap">one-hundredth</FONT> of one cent or the nearest share, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Notice of Adjustments</U>. Upon the occurrence of each adjustment pursuant to this <U>Section</U><U></U><U>&nbsp;9</U>, the Company at
its expense will, at the written request of the Holder, promptly compute such adjustment, in good faith, in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment, including a statement of the adjusted
Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts upon which such
adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder and to the Company&#146;s transfer agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Notice of Corporate Events</U>. If, while this Warrant is outstanding, the Company (i)&nbsp;declares a dividend or any other
distribution of cash, securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or warrants to subscribe for or purchase any capital stock of the Company or any subsidiary,
(ii)&nbsp;authorizes or approves, enters into any agreement contemplating or solicits stockholder approval for any Fundamental Transaction or (iii)&nbsp;authorizes the voluntary dissolution, liquidation or winding up of the affairs of the Company,
then, except if such notice and the contents thereof shall be deemed to constitute material <FONT STYLE="white-space:nowrap">non-public</FONT> information, the Company shall deliver to the Holder a notice of such transaction at least ten
(10)&nbsp;days prior to the applicable record or effective date on which a Person would need to hold Common Stock in order to participate in or vote with respect to such transaction; provided, however, that the failure to deliver such notice or any
defect therein shall not affect the validity of the corporate action required to be described in such notice. In addition, if while this Warrant is outstanding, the Company authorizes or approves, enters into any agreement contemplating or solicits
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stockholder approval for any Fundamental Transaction contemplated by <U>Section</U><U></U><U>&nbsp;9(c)</U>, other than a Fundamental Transaction under clause (iii)&nbsp;of
<U>Section</U><U></U><U>&nbsp;9(c)</U>, then, except if such notice and the contents thereof shall be deemed to constitute material <FONT STYLE="white-space:nowrap">non-public</FONT> information, the Company shall deliver to the Holder a notice of
such Fundamental Transaction at least ten (10)&nbsp;days prior to the date such Fundamental Transaction is consummated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. <I>Payment of</I> <I>Cashless
Exercise Price</I>. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a &#147;cashless exercise,&#148; in which event the Company shall issue
to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section&nbsp;3(a)(9) of the Securities Act as determined as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">X = Y <FONT STYLE="white-space:nowrap">[(A-B)/A]</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;X&#148; equals the
number of Warrant Shares to be issued to the Holder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Y&#148; equals the total number of Warrant Shares with respect to which this
Warrant is then being exercised; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;A&#148; equals the Closing Sale Price per share of Common Stock as of the Trading Day on the date
immediately preceding the Exercise Date; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;B&#148; equals the Exercise Price per Warrant Share then in effect on the Exercise
Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in such a
&#147;cashless exercise&#148; transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the Original Issue Date (provided that the Commission continues to
take the position that such treatment is proper at the time of such exercise). In the event that the Registration Statement or another registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of
exercise of this Warrant, then this Warrant may only be exercised through a cashless exercise, as set forth in this <U>Section</U><U></U><U>&nbsp;10</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In no event will the exercise of this Warrant be settled in cash. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. <I>Limitations on Exercise</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
Notwithstanding anything to the contrary contained herein (but subject to <U>Section</U><U></U><U>&nbsp;11(b)</U>), the Company shall not effect any exercise of this Warrant, and the Holder shall not be entitled to exercise this Warrant for a number
of Warrant Shares in excess of that number of Warrant Shares that, upon giving effect or immediately prior to such exercise, would cause (i)&nbsp;the aggregate number of shares of Common Stock beneficially owned by the Holder, its Affiliates and any
other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder&#146;s for purposes of Section&nbsp;13(d) of the Exchange Act to exceed 9.99% (the &#147;<B>Maximum Percentage</B>&#148;) of the total number of issued and
outstanding shares of Common Stock of the Company following such exercise, or (ii)&nbsp;the combined voting power of the securities of the Company beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership
of Common Stock would be aggregated with the Holder&#146;s for purposes of Section&nbsp;13(d) of the Exchange Act to exceed 9.99% of the combined voting power of all of the securities of the Company then outstanding following such exercise. For
purposes of this Warrant, in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (x)&nbsp;the Company&#146;s most recent Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> or Form <FONT STYLE="white-space:nowrap">10-K,</FONT> as the case may be, filed with the Commission prior to the date hereof, (y)&nbsp;a more recent public announcement by the Company or (z)&nbsp;any other
notice by the Company or its transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written request of the Holder, the Company shall within three (3)&nbsp;Trading Days confirm in writing or by electronic mail to the
Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant,
by the Holder since the date as of which such number of outstanding shares of Common Stock was reported. For purposes of this <U>Section</U><U></U><U>&nbsp;11(a)</U>, the aggregate number of shares of Common Stock or voting securities beneficially
owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder&#146;s for purposes of </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Section&nbsp;13(d) of the Exchange Act shall include the shares of Common Stock issuable upon the exercise of this Warrant with respect to which such determination is being made, but shall
exclude the number of shares of Common Stock that would be issuable upon (x)&nbsp;exercise of the remaining unexercised and <FONT STYLE="white-space:nowrap">non-cancelled</FONT> portion of this Warrant by the Holder and (y)&nbsp;exercise or
conversion of the unexercised, <FONT STYLE="white-space:nowrap">non-converted</FONT> or <FONT STYLE="white-space:nowrap">non-cancelled</FONT> portion of any other securities of the Company that do not have voting power (including without limitation
any securities of the Company that would entitle the holder thereof to acquire at any time Common Stock, including without limitation any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or
exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock), is subject to a limitation on conversion or exercise analogous to the limitation contained herein and is beneficially owned by the Holder or any of
its Affiliates and other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder&#146;s for purposes of Section&nbsp;13(d) of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Nothing in <U>Section</U><U></U><U>&nbsp;11(a)</U> shall in any manner restrict or limit the Alternate Consideration that a Holder shall
be entitled to receive pursuant to Section&nbsp;9(c) upon the occurrence of a Fundamental Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. <I>No Fractional Shares</I>. No fractional
Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any fractional shares that would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded down to the next whole number and the
Company shall pay the Holder in cash the fair market value (based on the Closing Sale Price) for any such fractional shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. <I>Notices</I>. Any and
all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in writing and shall be deemed given and effective on the earliest of (i)&nbsp;the date of transmission, if such notice or
communication is delivered via facsimile or confirmed <FONT STYLE="white-space:nowrap">e-mail</FONT> prior to 5:30 P.M., New York City time, on a Trading Day, (ii)&nbsp;the next Trading Day after the date of transmission, if such notice or
communication is delivered via facsimile or confirmed <FONT STYLE="white-space:nowrap">e-mail</FONT> on a day that is not a Trading Day or later than 5:30&nbsp;P.M., New York City time, on any Trading Day, (iii)&nbsp;the Trading Day following the
date of mailing, if sent by nationally recognized overnight courier service specifying next business day delivery, or (iv)&nbsp;upon actual receipt by the Person to whom such notice is required to be given, if by hand delivery. The addresses,
facsimile numbers and <FONT STYLE="white-space:nowrap">e-mail</FONT> addresses for such communications shall be: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to
the Company: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kopin Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: Richard Sneider </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">125 North Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Westborough, MA 01581 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Morgan, Lewis&nbsp;&amp; Bockius LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">One Federal Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Boston, MA 02110 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: John J. Concannon III </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If to the Holder, to its mailing address or <FONT STYLE="white-space:nowrap">e-mail</FONT> address set forth herein or on the books and
records of the Company, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or, in each of the above instances, to such other address, facsimile number or <FONT STYLE="white-space:nowrap">e-mail</FONT>
address as the recipient party has specified by written notice given to each other party at least five (5)&nbsp;days prior to the effectiveness of such change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14. <I>Warrant Agent</I>. The Company shall initially serve as warrant agent under this Warrant. Upon ten (10)&nbsp;days&#146; notice to the Holder, the
Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting from any consolidation to which the Company or any new warrant agent shall be a party or any
corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant
agent shall promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder&#146;s last address as shown on the Warrant Register. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15. <I>Miscellaneous</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>No Rights as a Stockholder</U>. The Holder, solely in such Person&#146;s capacity as a holder of this Warrant, shall not be entitled to
vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person&#146;s capacity as the Holder of this
Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, amalgamation, conveyance
or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares that such Person is then entitled to receive upon the due exercise of this Warrant. In
addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are
asserted by the Company or by creditors of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Authorized Shares</U>. Except and to the extent as waived or consented to
by the Holder, the Company shall not by any action, including, without limitation, amending its certificate or articles of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such
actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (a)&nbsp;not increase the par value of any Warrant Shares
above the amount payable therefor upon such exercise immediately prior to such increase in par value, (b)&nbsp;take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> Warrant Shares upon the exercise of this Warrant, and (c)&nbsp;use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof as may be necessary to enable the Company to perform its obligations under this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Successors and
Assigns</U>. Subject to compliance with applicable securities laws, this Warrant may be assigned by the Holder. This Warrant may not be assigned by the Company without the written consent of the Holder, except to a successor in the event of a
Fundamental Transaction. This Warrant shall be binding on and inure to the benefit of the Company and the Holder and their respective successors and assigns. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to
any Person other than the Company and the Holder any legal or equitable right, remedy or cause of action under this Warrant. This Warrant may be amended only in writing signed by the Company and the Holder, or their successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Amendment and Waiver</U>. Except as otherwise provided herein, the provisions of the Warrants may be amended and the Company may take
any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Acceptance</U>. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions
contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Governing Law; Jurisdiction</U>. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND
INTERPRETATION OF THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY
SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR
DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE
JURISDICTION OF ANY </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
SUCH COURT. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY
THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PERSON AT THE ADDRESS IN EFFECT FOR NOTICES TO IT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE
THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit
or affect any of the provisions hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Severability</U>. In case any one or more of the provisions of this Warrant shall be
invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby, and the Company and the Holder will attempt in good faith to agree
upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its
authorized officer as of the date first indicated above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KOPIN CORPORATION</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Warrant</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF EXERCISE NOTICE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[To be executed by the Holder to purchase shares of Common Stock under the Warrant] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) The undersigned is the Holder of
Warrant No. <U>&nbsp;&nbsp;&nbsp;&nbsp;</U> (the &#147;Warrant&#148;) issued by Kopin Corporation, a Delaware corporation (the &#147;Company&#148;). Capitalized terms used herein and not otherwise defined herein have the respective meanings set
forth in the Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) The undersigned hereby exercises its right to purchase Warrant Shares pursuant to the Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(3) The Holder intends that payment of the Exercise Price shall be made as (check one): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Cash Exercise</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#147;Cashless Exercise&#148; under Section&nbsp;10 of the Warrant</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(4) If the Holder has elected a Cash Exercise, the Holder shall pay the sum of $ __________ in immediately available funds to
the Company in accordance with the terms of the Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(5) Pursuant to this Exercise Notice, the Company shall deliver to the Holder such number of
Warrant Shares determined in accordance with the terms of the Warrant. The Warrant Shares shall be delivered to the following DWAC Account Number: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:26%">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(6) By its delivery of this Exercise Notice,
the undersigned represents and warrants to the Company that in giving effect to the exercise evidenced hereby, the Holder will not beneficially own in excess of the number of shares of Common Stock (as determined in accordance with
Section&nbsp;13(d) of the Securities Exchange Act of 1934, as amended) permitted to be owned under Section&nbsp;11(a) of the Warrant to which this notice relates. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="66%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dated:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name&nbsp;of&nbsp;Holder:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Signature must conform in all respects to name of Holder as specified on the face of the Warrant) </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>d432826dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;26, 2023 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kopin Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">125 North Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Westborough, MA 01581 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion is furnished to you in
connection with the filing of a prospectus supplement, dated January&nbsp;24, 2023 (the &#147;<U>Prospectus Supplement</U>&#148;), to a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> Registration <FONT
STYLE="white-space:nowrap">No.&nbsp;333-253933</FONT> (the &#147;<U>Registration Statement</U>&#148;) filed by Kopin Corporation, a Delaware corporation (the &#147;<U>Company</U>&#148;), with the Securities and Exchange Commission (the
&#147;<U>Commission</U>&#148;) under the Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), with respect to the sale of up to 17,000,000 shares of the Company&#146;s common stock (the &#147;<U>Shares</U>&#148;), <FONT
STYLE="white-space:nowrap">pre-funded</FONT> warrants to purchase up to an aggregate of 6,000,000 shares of the Company&#146;s common stock (the &#147;<U><FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants</U>&#148;, and such shares issuable
upon exercise of the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants, the &#147;<U><FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrant Shares</U>&#148;), pursuant to the Underwriting Agreement (the &#147;<U>Underwriting
Agreement</U>&#148;), dated January&nbsp;24, 2023 by and between the Company and Stifel, Nicolaus&nbsp;&amp; Company, Incorporated, as representative of the several Underwriters named therein. The Shares and the Warrants (collectively, the
&#147;<U>Securities</U>&#148;) are to be sold pursuant to the Prospectus Supplement and the base prospectus included in the Registration Statement, dated April&nbsp;27, 2022 (together with the Prospectus Supplement, the
&#147;<U>Prospectus</U>&#148;). The Underwriting Agreement is being filed as an exhibit to a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and will be incorporated by reference into the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As to all matters of fact (including factual conclusions and characterizations and descriptions of purpose, intention or other state of mind), we have relied,
with your permission, entirely upon written actions by the board of directors of the Company and certificates of certain officers of the Company and have assumed, without independent inquiry, the accuracy of those certificates and written actions by
the board of directors of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As counsel to the Company, in rendering the opinions hereinafter expressed, we have examined and relied upon
originals or copies of such corporate records, agreements, documents and instruments as we have deemed necessary or advisable for purposes of this opinion, including (i)&nbsp;the certificate of incorporation and
<FONT STYLE="white-space:nowrap">by-laws</FONT> of the Company, (ii)&nbsp;the Registration Statement and the exhibits thereto filed with the Commission, (iii)&nbsp;the Prospectus, (iv)&nbsp;the Underwriting Agreement, (v)&nbsp;the <FONT
STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants, and (vi)&nbsp;the written actions of the board of directors referenced above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion is
limited solely to the Delaware General Corporation Law without regard to choice of law, to the extent that the same may apply to or govern the transactions contemplated by the Registration Statement. We express no opinion as to the effect of events
occurring, circumstances arising, or changes of law becoming effective or occurring, after the date hereof on the matters addressed in this opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With
respect to the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants, we have assumed that, as of each and every time any of the Warrants are exercised, the Company will have a sufficient number of authorized and unissued shares of the Common
Stock available for issuance under its certificate of incorporation to permit full exercise of each of the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants in accordance with their terms without the breach or violation of any other
agreement, commitment or obligation of the Company. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon the foregoing, we are of the opinion that (i)&nbsp;the Shares have been duly authorized by the
Company and, when issued and sold by the Company and delivered by the Company against receipt of the purchase price therefor, in the manner contemplated by the Underwriting Agreement, will be validly issued, fully paid and <FONT
STYLE="white-space:nowrap">non-assessable;</FONT> (ii)&nbsp;when the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants are issued, sold and delivered in the manner and for the consideration stated in the Registration Statement and the
Prospectus, such <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and other laws of general applicability relating to or affecting creditors&#146; rights and to general equity principles; and (iii)&nbsp;the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrant Shares, when
issued and delivered by the Company upon exercise of the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants in accordance with the terms thereof, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Registration Statement and to the reference to us under the caption
&#147;Legal Matters&#148; in the Prospectus. In giving such consent, we do not admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Act, or the rules and regulations of the Commission thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Morgan, Lewis&nbsp;&amp; Bockius LLP
</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>d432826dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Kopin Announces Proposed Public Offering of Common Stock and <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jan 24, 2023 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WESTBOROUGH, Mass. &#150; Kopin Corporation
(Nasdaq:&nbsp;<U>KOPN</U>), a leading provider of application-specific optical solutions for defense, enterprise, industrial, and consumer products, today announced that it intends to offer shares of its common stock and <FONT
STYLE="white-space:nowrap">pre-funded</FONT> warrants for sale in an underwritten public offering. Kopin intends to grant the underwriters of the offering a <FONT STYLE="white-space:nowrap">30-day</FONT> option to purchase up to an additional 15% of
the number of shares of common stock sold in connection with the offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size
or terms of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kopin intends to use the net proceeds from the offering for working capital and general corporate purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stifel is acting as sole book running manager in connection with the public offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC&#146;s
website located at&nbsp;<U>www.sec.gov</U>. When available, copies of the preliminary prospectus supplement and the accompanying prospectus relating to the offering may be obtained from Stifel, Nicolaus&nbsp;&amp; Company, Incorporated, Attention:
Syndicate, One Montgomery Street, Suite 3700, San Francisco, California 94104, or by telephone at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">415-364-2720</FONT></FONT> or by email at&nbsp;<U>syndprospectus@stifel.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before investing in the offering, you should read in their entirety the preliminary prospectus supplement and its accompanying prospectus to be filed with the
SEC, and the other documents that Kopin has filed with the SEC that will be incorporated by reference in the prospectus supplement and its accompanying prospectus, which will provide more information about Kopin and the offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any offer or sale of these securities in any
state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Kopin </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kopin Corporation is a leading provider of
application-specific optical solutions for defense, enterprise, industrial, and consumer products. Kopin&#146;s technology portfolio includes ultra-small microdisplays (AMLCD, OLED, FLCOS and MicroLED displays), optics, speech enhancement
technology, and <FONT STYLE="white-space:nowrap">low-power</FONT> ASICs. For more information, please visit Kopin&#146;s website at&nbsp;<U>www.kopin.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-Looking Statements </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Statements in this press release may
be considered &#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the
&#147;Exchange Act&#148;), which are subject to the safe harbor created by such sections. Words such as &#147;intends,&#148; &#147;expects,&#148; &#147;believes,&#148; &#147;can,&#148; &#147;will,&#148; and variations of such words and similar
expressions, and the negatives thereof, are intended to identify such forward-</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
looking statements. These forward-looking statements include statements about the offering, Kopin&#146;s intention to grant the underwriters a <FONT STYLE="white-space:nowrap">30-day</FONT>
option to purchase additional shares in the offering, and Kopin&#146;s intended use of proceeds generated from the offering. We caution readers not to place undue reliance on any such &#147;forward-looking statements,&#148; which speak only as of
the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. All such forward-looking
statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, we disclaim any
obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as may otherwise be required by the federal securities laws. These forward-looking statements are only predictions,
subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management&#146;s expectations are described in Part I,
Item 1A. Risk Factors; Part II, Item 7. Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended
December&nbsp;25, 2021, as updated from time to time in our Securities and Exchange Commission filings. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Kopin</B><B> Investor Relations </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Richard Sneider, (508) <FONT STYLE="white-space:nowrap">870-5959</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CFO </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>rsneider@kopin.com</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OR </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">JoAnn Horne, (415)
<FONT STYLE="white-space:nowrap">445-3233</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Market Street Partners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>JHorne@marketstreetpartners.com</U> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>d432826dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Kopin Announces Pricing of Public Offering </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jan 25, 2023
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WESTBOROUGH, Mass. &#150; Kopin Corporation (Nasdaq:&nbsp;<U>KOPN</U>), a leading provider of application-specific optical solutions for defense,
enterprise, industrial, and consumer products, today announced that it has priced an underwritten public offering of 14,000,000 shares of its common stock at a public offering price of $1.00 per share. In addition, in lieu of common stock to certain
investors, Kopin today announced the pricing of its public offering of <FONT STYLE="white-space:nowrap">pre-funded</FONT> warrants to purchase up to 6,000,000 shares of common stock at a public offering price of $0.99 per <FONT
STYLE="white-space:nowrap">pre-funded</FONT> warrant, which equals the public offering price per share of the common stock less the $0.01 per share exercise price of each <FONT STYLE="white-space:nowrap">pre-funded</FONT> warrant. In addition, the
Company has granted the underwriter a <FONT STYLE="white-space:nowrap">30-day</FONT> option to purchase up to an additional 3,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The aggregate gross proceeds from the Offering will be approximately $19.9&nbsp;million, before deducting discounts and commissions and other estimated
offering expenses. Kopin intends to use the net proceeds it receives from the offering for working capital and general corporate purposes. The offering is expected to close on January&nbsp;27, 2023, subject to the satisfaction of customary closing
conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stifel is acting as sole book running manager in connection with the public offering. H.C. Wainwright&nbsp;&amp; Co. is acting as financial
advisor to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This offering is being made only by means of a prospectus supplement and accompanying base prospectus that form a part of the
registration statement. A preliminary prospectus supplement relating to and describing the terms of the offering was filed with the SEC on January&nbsp;24, 2023, copies of which may be obtained for free by visiting EDGAR on the SEC&#146;s website at
www.sec.gov. The final prospectus supplement and accompanying base prospectus may also be obtained, when available, by sending a request to: Stifel, Nicolaus&nbsp;&amp; Company, Incorporated, Attention: Prospectus Department, One Montgomery Street,
Suite 3700, San Francisco, CA 94104, by telephone at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">415-364-2720.</FONT></FONT> The final terms of the offering will be disclosed in a final prospectus supplement to be filed with
the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Company&#146;s ordinary shares or any other
securities, and there shall not be any offer, solicitation, or sale of securities mentioned in this press release in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under
the securities laws of such any state or jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Kopin </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kopin Corporation is a leading provider of application-specific optical solutions for defense, enterprise, industrial, and consumer products. Kopin&#146;s
technology portfolio includes ultra-small microdisplays (AMLCD, OLED, FLCOS and MicroLED displays), optics, speech enhancement technology, and <FONT STYLE="white-space:nowrap">low-power</FONT> ASICs. For more information, please visit Kopin&#146;s
website at&nbsp;<U>www.kopin.com</U>. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-Looking Statements </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Statements in this press release may be considered &#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933,
as amended (the &#147;Securities Act&#148;), and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), which are subject to the safe harbor created by such sections. Words such as &#147;intends,&#148;
&#147;expects,&#148; &#147;believes,&#148; &#147;can,&#148; &#147;will,&#148; and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. These forward-looking statements
include statements about the offering and Kopin&#146;s intended use of proceeds generated from the offering. We caution readers not to place undue reliance on any such &#147;forward-looking statements,&#148; which speak only as of the date made, and
advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. All such forward-looking statements, whether
written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, we disclaim any obligation to update
any forward-looking statements to reflect events or circumstances after the date of this press release, except as may otherwise be required by the federal securities laws. These forward-looking statements are only predictions, subject to risks and
uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management&#146;s expectations are described in Part I, Item 1A. Risk
Factors; Part II, Item 7. Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended
December&nbsp;25, 2021, as updated from time to time in our Securities and Exchange Commission filings. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Kopin Investor Relations</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>Richard Sneider, (508) <FONT STYLE="white-space:nowrap">870-5959</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CFO </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>rsneider@kopin.com</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OR </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">JoAnn Horne, (415)
<FONT STYLE="white-space:nowrap">445-3233</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Market Street Partners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>JHorne@marketstreetpartners.com</U> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>kopn-20230124.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 1/27/2023 2:15:51 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:kopn="http://kopin.com/20230124"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://kopin.com/20230124"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kopn-20230124_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kopn-20230124_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>kopn-20230124_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 1/27/2023 2:15:51 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>kopn-20230124_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 1/27/2023 2:15:51 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="kopn-20230124.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140582706688544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 24, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">KOPIN CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000771266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 24,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-19882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2833935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">125 North Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Westborough<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(508)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">870-5959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KOPN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>d432826d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="kopn-20230124.xsd" xlink:type="simple"/>
    <context id="duration_2023-01-24_to_2023-01-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
        </entity>
        <period>
            <startDate>2023-01-24</startDate>
            <endDate>2023-01-24</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-01-24_to_2023-01-24"
      id="Hidden_dei_EntityRegistrantName">KOPIN CORP</dei:EntityRegistrantName>
    <dei:SecurityExchangeName
      contextRef="duration_2023-01-24_to_2023-01-24"
      id="Hidden_dei_SecurityExchangeName">NASDAQ</dei:SecurityExchangeName>
    <dei:AmendmentFlag contextRef="duration_2023-01-24_to_2023-01-24">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-01-24_to_2023-01-24"
      id="Hidden_dei_EntityCentralIndexKey">0000771266</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-01-24_to_2023-01-24">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-01-24_to_2023-01-24">2023-01-24</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-01-24_to_2023-01-24">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-01-24_to_2023-01-24">000-19882</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-01-24_to_2023-01-24">04-2833935</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-01-24_to_2023-01-24">125 North Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-01-24_to_2023-01-24">Westborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-01-24_to_2023-01-24">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-01-24_to_2023-01-24">01581</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-01-24_to_2023-01-24">(508)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-01-24_to_2023-01-24">870-5959</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-01-24_to_2023-01-24">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-01-24_to_2023-01-24">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-01-24_to_2023-01-24">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-01-24_to_2023-01-24">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-01-24_to_2023-01-24">Common Stock, par value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-01-24_to_2023-01-24">KOPN</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-01-24_to_2023-01-24">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *6".E8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "E@CI6OU-N(^X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)VUAP=#M1?&D(+B@> N3V=U@TX1DI-VW-ZV[740?0,@E,W^^
M^0;28E#H(SU''RBRI70SN7Y("L-6')F# DAX)*=3F1-#;NY]=)KS-1X@:/S0
M!X):R@TX8FTT:YB!15B)HFL-*HRDV<<SWN"*#Y^Q7V &@7IR-'""JJQ =//$
M<)KZ%JZ &<847?HND%F)2_5/[-(!<4Y.R:ZI<1S+L5ER>8<*WIX>7Y9U"SLD
MU@-2?I6LXE.@K;A,?FWN[G</HJMEW12R*NK-KJY4/O+V?7;]X7<5=M[8O?W'
MQA?!KH5?_Z+[ E!+ P04    " "E@CI6F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M *6".E8X;>!O/@0  'D0   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9AM;_(V%(;_BI5-TR:US0OO'2!1VCYC?=JRPE9ITSZ8Q(#5Q,YLI[3_?L<)
M).Q9.($/$"<^=R[[V+=MACNIWO26,4,^DECHD;,U)KUV71UN64+UE4R9@"=K
MJ1)JH*@VKDX5HU$>E,1NX'E=-Z%<..-A?F^NQD.9F9@+-E=$9TE"U><-B^5N
MY/C.X<8+WVR-O>&.ARG=L 4SOZ=S!26W5(EXPH3F4A#%UB-GXE_?!&T;D-?X
M@[.=/KHFMBDK*=]L81:-',\2L9B%QDI0^'EG4Q;'5@DX_MF+.N4[;>#Q]4']
M/F\\-&9%-9O*^)5'9CMR^@Z)V)IFL7F1NU_8OD$=JQ?*6.??9%?4;7L."3-M
M9+(/!H*$B^*7?NP[XBB@=2H@V <$.7?QHISREAHZ'BJY(\K6!C5[D3<UCP8X
M+FQ6%D;!4PYQ9GPKPPPZV1 J(G(G##>?9":*;$.O#5T#+[%5W7 O>%,(!B<$
M?Z7BB@3M"Q)X0>N_X2ZPE8!!"1CD>JT3>E/YSA3Y:[+21D$*_ZXC*A3:]0IV
M7%_KE(9LY,# U4R],V?\PW=^U_L9X6N5?"U,?;SOLQ>VX980>O*))JR.$M=Y
M>)[/GLCT^66.0+5+J#8JMF!AIBS6W4>XI6+#3D+A.D^3Q>WD-P2H4P)U4*$)
MC+$H'V?W,=W4@>#Q:QIKAG!T2X[N.=F: HFB,8STB'V0!_991X0K>?#I]?R@
MVT6P>B56#Q4K9^'R,ZU-$Q[>OWQ (/HE1/\\B#E37%HWB AX2BT/KE1Z0),)
M#$JTP3EIFXE0JE2JW)K(P@ <F<H,<@DIE5$M*2Y\>X?0^5YEHMXY?/<\AIF6
M)2NF:HT3%X$!=>D/^OT 0SKR=?\<I"7](+,(LLK7/"SZ#0'$);WV9=!OM0:M
M#D98&;N/^O*!<!)%X,KZXG!!OD(]\BQJL]D@Z0<=\B25V9);!8L]AEGYNW^6
MP9>84UN2BBSEKGYYQ.5>F38KJ62VV6)XE=/[N$5_BU?,"N";*_G.15C?C;CF
MXP1#JSS?QTW[6[2YU 9,]T^>GIRM#8J>W^G[&%NU#OBX?>=9G, ^]C0*+O!C
MQ^O_A*%4WN_C[OU5AM K\ZT4J'DT+ $][[(SZ PPHFHA\''_?H6]@V$"NB9)
M,K'W#5U+A0LU+=M^M0#XN%$O9,Q#;KC8D$<8X(K3N)8'5VGB"2K'#W"SGBN6
M=P^#&5:LW+#!@8WJ\WI=G[\&O4:RRO@#W*7_1S;3.@.R1D!<MA'P:$./FW2Y
M.?6#%5ER$]=.OP81V\)\#R##MPN24D7>:9PQ\KUWY6$.$52^'^!&O50TLL-M
M\9FL9.U@:Q" '?T31E)9?'"6Q=\E3&TLT1=0@"4.NB"EHG;KVB!X,I?NT4'2
M'LH?J7VC)C%;@Y!WU0-[5L4YMR@8F>9GRY4T<%+-+[>,PCBS%>#Y6DIS*-CC
M:OEOP_A?4$L#!!0    ( *6".E:?H!OPL0(  .(,   -    >&PO<W1Y;&5S
M+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9 8;"-0O-A7Y58=@1Z\62Y<_KKI[-L
M)VEU9=V'L<VAR=T]NKM'=R>9KEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT
M7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//
MEI0&@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC
M**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QK
MRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3), Z)Q17B@%JXUF X?)
M8Q1\V .7\@%:^*VZBMU7)/3B4PEM(+#52?2$1C&$"0K$OXP68E^$O?VML*01
MC\9][/QN]*!_[XSC]Y97HA_TOIKS8]$7>'36-/+T08I:*Q[V_LL)BS6;_,C1
M6/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_
M-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+
M_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5
MUOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0_00,X[:*(BO4
M9X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM
M\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/
MFD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8*<D3?,\C@ 69Y"F& *G$4<P!L !
M0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( *6".E:7BKL<P    !,"   +
M    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*
M19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>
M-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS
M#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C
M(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ I8(Z5APX9>H_
M 0  / (   \   !X;"]W;W)K8F]O:RYX;6R-4<MNPD ,_)75?D 34(M41+B4
M/I"J%I6*^Y)UB,4^(J\#+5]?)U%4I%YZ\GILC6=F%^=(QWV,1_7E74B%KIF;
M>9:EL@9OTDUL(,BDBN0-2TN'+#4$QJ8:@+W+IGD^R[S!H)>+D6M#V743&4K&
M& 3L@!W".?W.NU:=,.$>'?)WH?NW ZT\!O1X 5OH7*M4Q_-+)+S$P,9M2XK.
M%7HR#'9 C.4?>-N)_#3[U"-L]A]&A!1ZE@MAA92XW^CYC6@\@2P/7<OQ"1T#
MK0S#,\6VP7#H:,1%=F6CSV&L0XAS^D^,L:JPA%4L6P^!AQP)7"<PI!J;I%4P
M'@H]KB@3K'H,+"&I=1BH9+=S*J?7=G#-(O<J0YJC#&AM!^&C6@L5!K!O<B )
M+LF5&U)=Z7FFMW>3>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0    ( *6".E8D
M'INBK0   /@!   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.
M@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4
M=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[N
MF:*<//Y#='7=:7PX_;(X\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF*
M*I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    " "E
M@CI699!YDAD!  #/ P  $P   %M#;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0
MA:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS>
MCQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[
ME.O5,[1R;ZEXZ7D;3?!-F<!B63R-PLQJ2AFC-4H2U\7!ZQ^4ZD2HN7/08&<B
M+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:
M8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X
M(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA
M/UY_ 5!+ 0(4 Q0    ( *6".E8'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ I8(Z5K]3;B/N
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ I8(Z5IE<G",0!@  G"<  !,              ( !S $  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " "E@CI6.&W@;SX$  !Y$   &
M            @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ I8(Z5I^@&_"Q @  X@P   T              ( !@0P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " "E@CI6EXJ[',     3 @  "P
M    @ %=#P  7W)E;',O+G)E;'-02P$"% ,4    " "E@CI6'#AEZC\!   \
M @  #P              @ %&$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ I8(Z5B0>FZ*M    ^ $  !H              ( !LA$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ I8(Z5F60>9(9 0  SP,
M !,              ( !EQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  X1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d432826d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, dei:SecurityExchangeName -  d432826d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d432826d8k.htm">d432826d8k.htm</File>
    <File>d432826dex11.htm</File>
    <File>d432826dex41.htm</File>
    <File>d432826dex51.htm</File>
    <File>d432826dex991.htm</File>
    <File>d432826dex992.htm</File>
    <File>kopn-20230124.xsd</File>
    <File>kopn-20230124_lab.xml</File>
    <File>kopn-20230124_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d432826d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d432826d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "kopn-20230124_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "kopn-20230124_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "kopn-20230124.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "kopn",
   "nsuri": "http://kopin.com/20230124",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d432826d8k.htm",
      "contextRef": "duration_2023-01-24_to_2023-01-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d432826d8k.htm",
      "contextRef": "duration_2023-01-24_to_2023-01-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kopin.com//20230124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001193125-23-016260-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-016260-xbrl.zip
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M7D38_X]F&6GZ97VBFE<"%@),P!PS.1!.!;"H!8CC<-6*=2.*J(VXBB%..S<
M[EDDVI@^D18A>E@LT#FU['BY$39A7AF"L[&;'$M)BCCGI5E.-<\?Z;)J- 2@
M1_J@3"1H*^O?=(I).FYT+*-W9=K4";<E(( 3%*\6C1J$["K0CTM'%;-MPI3I
M@1<N5:9&LTJ)K6'#"7B)RN'P7!!=7"-(@.\)Q>]2.R7.KJ2&:E '\DVI]1$0
M' <B7Z8'P2F5F@WF%QDI/9K8:!P7E3RHDA2?._;8UBM5G2VPN8 5S02X1$Z5
M.M%CI\FE?*D_0PA5Y(L#^I)'!NH]:2#4J'2 2T*4[&CO 4U#,&',S0!L8SVD
MZZJ<B+(K*C,C3V\DY<#+4?SZTM<0$O1-CE$*TR8$E< MB ?F:]:*[JVP>>K$
M"E=\9]D<1O)X3">=Q!(0<,='.R>H@_'5E5+1#=+%TFL-*CBZD3(=2]ZB40*,
M*2M;4][9$E?D6Z)*3Q:%@\/N29/'A,EM?S/[$,N#<1"?4BYYH$VN3/RQ0$5I
M$#HDC*[?D(%LSEDP0]3%;S",S,<@!,+(5Q9NP%(#)O)G&T"$Z<'%@JFU;,!U
M,^0<FSKJS3A;!R2I.GV*R?.1W0<-8A2,:)UV*C0F.L9-KU I2DP7/\_K3!:5
M@J,*<$@,'FB%VN*L98M,D/,<+WHG)M%NJ5SV/!=@&D4#^-GC0PKNW2<&TIU.
M9?P,DFM#X/;IT^-BAL%A0X CB =<S#A$^RC*\=HJW%^W<J7/TY'V"_"K?@E4
MBEW."\8Q],QAE@-.+^@(5#Q@_, %#T*I;!06T\I=NJ.J!CL^'9/NUP]G*0\Z
MNY7L>EQ/)/-5,I:09F& L5QZU#.<*LT;"PF1Q F3^:J9RH?@A4I+2)9>,G(\
M<!0<@F?GT FH2#RJZ<DU9/(L<$L+DG8J$T\P!00,(2(S)Z>6X"SP0XJV5\\M
M67U+I9>N:W_E5+I6' =*H^^D-DZLTTAOB7UTUIZEMG&]%&-Z?U&I3ODJ:W7*
M[4S+[[SQSY@LY0FLT[;E+=Z!>Y 3KZW??VW_W.Z1]OU=Z_<UXEY^Z:K5PZB#
M+<I6<1M1EZ[J#Y9BWNAJFR+3%?6MJK%6>>4BTZT+1"/-LN00[U8*9(O2/1*]
M[U]](T*^[X#MW*GL;1F7*D&[Z7-2Q*3^/J6**XN;OGOLW25^>E93)Z*P1.(7
MV2PZXHTM2_"8:@8O#&4><%5^Y1?(+9K)I872:9: >.VE>$F5^E&BOE# JE;*
M5^4+L!6&41@%,-JJ;(<E;<:*G>&^ROY%R9_%C6)L/>3.;6;'%BNFD@W;FR)=
M2=^_(R]57Y^7JIJ7/CP_B_!&S2Q1SE^?FN>:F@^[I2W>2(<GQRK'HU?3<X4L
M9MB27B<J]Z^26ZD4S.D;)0'1M=KK4[)6TZ1\E.^^ZC"'X<[J&E,,AM;U0M>4
MR4*YQY,<KXS3CU$:[XVLDJSEUR=K>5NRGB\GJ\]M^?F-HDO.$Y2J+TK0I@=W
MR2.L$)Q5\#^IJLZZHP$EL@3LA(W[S+)T>ESGSMLR>"+X;7S$TE]5@*</DK@G
MSE'AQZ30689#?]]JYZ.^4K_;_N6^T?O2:3UW$Z*ZZR;$XUSU(L=O/^2ZB&.[
M0S*J<J^3/21AA<Z,F!!\R8#)%M&FB]H3%;!X+!-2>UM]-J+.(*H6D!&7[H"1
M5HAEO7(XH-7(X[ P:UUR_J^;K5N:G\LR>?4R2J_MDK%;>RR\NM.(ZP:ZS*3^
M%A,LKZ&LUT"YZ\&_5Q]YR7=^[&]A40[6F5C9OFAC=^E[)'L<H0N_=\>JS_DQ
M%]$WY?SUR+_;6>H-QYEV- -%420=&[^KQ2*- NFZ#&C'7_TT]7<DS,NP^8;)
M?4;N 6JP^H_+Y&YS9+,!^+_16<D'5=[VAMS]1CYYC%]RG> 4\=Q(SJ!J%)]N
M&T3<%-478<NOR;[]'U!+ P04    " "E@CI6GTZ\$>AU  "+1P( $    &0T
M,S(X,C9D97@Q,2YH=&WMO6ESVU:V-OJ=5?P/J)SN4U(5K$BR8R>VVU6R+2?J
M=FR7A^[3]];] )*@A)@$& "4K/[U=XU[P@9)34S<Y;?>/K$D$MC#FH=G/?WE
MXZ^OGSW]Y?CHY;/AX.G'DX^OCY\=_]^]@[V#I]_S3_#K[^7OR=/G;U_^.WG^
M\XNWK]^^_]MW__KEY./Q=\^2X0 ^]"(OV[Q^]O3ER3^3#Q___?KX;]]=%)/V
M[/&/>S\4Y7=)-BM.R[]]-\NG[7?TK'?ZL7E6GQ;EO;9:/-Y?M$\2^7E4M6TU
MYU]-J[*]UQ3_R1\?V)^GV;R873[^6,SS)GF37R3OJWD&;SIZ??+SF[]]5Q>G
M9_"JI\^?'7\Y*T9%F\"NDJ??/W_V]/MWN*W8 @X.[V0%3T]@$?EXV195F?PS
MKQO\[]/O3YYM<SECNJ'OGAT\2/?W]_%_R8>SK(;/X@KB%_+P#M[_]-7;-Q^!
M:)1*SHHVO]<LLG'^N*PNZFSQW;-W=7[OU;*<Y).GW^.GGR7_RNHZ*]LF::OD
MW;(>GV5-GGQ:X(\/_]CM_./MNY,WR8NW[]^]?7_T\>3MFV3%A=[% EY4\SF0
MTX>V&G]>L??;Y"U]]<Y?]O?V#Y)W69W\,YLM\UV4%ENEI4_//KUY>?S^7^]/
M/IZ\^3DY^OG]\?&OQT!?3[__M&U&_WM6+K/Z\G_+4;-X<O@@30[W#^_?,34^
M^] 6TWR6)F^*<37+E@V__7^S^>+)< "DL<C*RS0Y*<=5O:CJK,TGUZ"1-O_2
MWBN '\OV\8._7G&%1TWR/E\ 8\*WL[8XSY-JFK1G>?(A/\_K;)9\@@?7%S6(
M@;I9Q3RW0<'/'OWXB%Y<MF?)$?QGF=\QSSS#?_Z[JC^GB?XK.=C?/_AIU59O
MA3R?O<XF!?PF*R?)S[#A63[/R\=W39#_J!9%F;P0<@-%ER99\C*?91<@G).Q
M_?UPL(-4\+__<_#@T1-6DD*OJAGQ3S\^V4V315TMJB8GZ5\T#=P9[JG)9S/\
M#3ZE$5I:NK2T RPQR\=(<S-@@O!M+MT%KTS*; Z< AL!"?-A?)9/EK,\.4&A
MPF\LX%A/ZQQ/M$UVZ&?WT4?ZM_"YTZH>#B[.JGER62T3/)$,UE>>)EF3U#Z7
M=$['YZ+.(64E+ G>>PI,CBSFZ/F&%6/GB:^*>BY:,UPH/&#,BJ5!Q0)W $+^
M'(5\PD)_D=?\W.YC62.!AL=O=M8IW"]W33?))L$*@P V?F_J&007:A!TWJZF
M0K@CN+>%6@Y+LAS"$WL8'AC\SM.N0 _X-KC$>9*U;8:$D9SE< ;XM :8^9.Q
M-H^06/:2C^Y69TWET7*,@EVJA$MMZ8_5@DQ'.3K_(W8ODTF!'X.'W%^WD\ZI
MO>4W1(F!=^$0"UT:/H&_!3<MOX:3P.,HRFP*BP.*GN9U#6<$"W1Y$:D]7(#_
M9OC%'OZ;5T#O#UYM+$+[4N]]L5> "0ZG5MC7[#G/[[MSD#?9:(8T [_+O^3U
MN&A4APT'UUB&?"4X:UU*OWB^':4 :SC8(S_()4TC>_B +ZRYG=(O2-@UR471
MGJ5)#H0_'$2($7Z1M:LTS*UM82?;[>P!.!NX*P=!!4>/BYX6,_@7KEGL#;U^
M^NOQ%Y %Y2E]?PZWC.2_0W<:RC+^8RA/,CBTTZ)I69N!F 0I0NH ?;MU NT5
MB! VU3[<NZ\R;><5+'C]=]]4>_S5^_?OWSO\X?Y/]^_OIOH,4HS+\5D""JR<
MS'/QF>A7/>N%8YMGE\/!609:9Y3G2,"_+PLA8#RYB0A(TG-&MZ6L;<.S/1JW
MI'Y@62D^FQ8"S^J('/\[$7W&C%Z#ZN4;@_4O9[3ZB-A_;S[VWGXLHM5$]\BE
M#@<M,BUM9"_YT']*)(J1RDY!@H$: )I,01^,9\L)J6\4[\Z)XT.1^UL^>?XX
MOCIG]< KQ6\U8EVL^M*D&B_YP85KR(\N6=3DY3CG;X/P 1T' @NN%9YT FMG
M4CDXQ+TCU24;^-\.3?9>L;M*<U=VH?B;HD1-R0=9X?HN4').D'J(M$;P1;0K
M6EX\++"JY4SSB=D0[!+O-GEP?_]Y_W*B]$#?&0Y.[#HZ!%$[*W./#A\7):G@
M>H A9)WC;#;C90=6FT-.'Y2<8@HH_DDU >B<P:ZHP-L$_3H#+3K*QT!S23Z=
MLF+M+(:HVUO-20E'!@;"9JLZ(LT0%1HL6^%N7%O./4 ^_X>'.Z/=_EN#!?<=
MF_/UU8M-9;%P3VDRK<&TAG\-!VR!&.E%%(I'"%0&:T>>%6&P_DW,A/"X^15N
M5E8%5@78>$+4Q/#KW[=W]ZXATAM8HLT"*&?9>(8M_!MD A X$%NV6.2D3N4#
MJ\EG/3,\1^/[G7EO2&_'9%B #I\5<Z#Q^M)=8[-<+&;\'N'/X&G)CI7'L3^#
M+FHJYS'Y9)<,%I!(S;@N1K+>P$P@\QLXK);'HIQ*^7O5O&A;^98548ZTD0?
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MF[F"=B]Y4V&^;@$?PJTT2V#ZTG@59N]EWI@7]6@@-2# [FGOV4.S]H1&*T7
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MV9GHK:PH6O$E4"A[Z-PT\Y)R86IP:HW4<2VE>\$R,6\I0KTV]T,@6P:8T33
MT0E0@C^?%\NY_7U>DJOT7,3]S\L,Z^,N8=T6]Z,G/Z3\C<%G*?S>97PY9C^2
MEWST#E2QD#.0,MAWK"%JTC+I2I\S8+#] R GT37,8T\XKN(DDRSU=) LV1JR
MH"!\L,$[#D HN+Q W1$NE$CF3-OK-Q* :<YP$R[#6*["K,-82Y?A!P>Y)$,;
MD]40BW6&@\6'<QG15*K\O"+3[1@1HU$WQ*)Q3<^>&F=US4TZZ 38PJ345B8Y
MS8GT.S%Q2VG[F%T2-NLIP>O8 "O'E# ?(LQ1"-X5V.!+;6*G]YEBS[IH/E,"
MFZHB0"%AJ&IJ722%GFFI1ML#R?&R_VU8PRU!)7@L6^S()%/R<O!DR*QDL Y:
MI#1M^L@>^EOP+I8(K)I+1[K "=JC GF^;"U6#P/X4.K>&U7HCER]:V(8C^/$
MP%UB$2^<[!-!/8,]2A=MRC%S;,4:2U&!HA!A-'0N4[ZF>!)GV#?:9E\0U7=9
MESWXS2Y&H3>MU;$%%J@3"#&.VF :KJ,RZ3W.0L,BX64X>6BIF(4&N8Z6836Q
MTU5I]8UX\HSEN5FH(B6%0G@NKL=M;3M/XG"-EK,.4XYZ_3C$?UT7SL-O>;";
M##V<1"KS*6J$P7!F#U.:JN)LF@L2 _6+J5VG;?.S[$(C5()KABQ^J7*@TI%;
M6,J"(@'8%HM!;' 7>3G@?&+8;N<#1P*TF\;M95X1-D/%%(VSU1SXCT?2;!Y@
M2_7J>;YI*;4OAFW94=,!GZ$$Y8W:.,'C$B+H;>-TRXIX#6)'IAO;5NR<^=X(
MRCV9" W&5\&MB;-L(5 #E.C!QB[L 1/+RC80LPUA%R*"$P6_UW2%)5E-7I]K
M"Q9)8)#W*5K@L*:LU HMJ>7U\":VUY7,8&&QCF/^2V\S<8!-YO6IJ?[$6W8L
M[@@=;;^IMF@UL!?+%-1$*FAEBW,Z,J,7Y6Q3,0E23>^/21A9LT///FP9#!L1
M^3$^^AOY418+<=I9IWRF!PAQ?9/OK73YKFSE_8JJM:=35V45C9AU8I^!\%!O
M2U,KSG08QY#=I&+!QS\(TB,FU,_)+ WV\WD6V,@!LE0RQXQPF3(.X(:3:2/3
M9S.,@>?-O;=?9KF)MA[N[Q]V XG=SP8Q0;:[^S.O\'IPYT^S-@\U+REI7.9V
M[OOT]#J.B/;6X5PV(V$;D..&Y1M/%K!WFDL1H(AA[0DE6>-UA>*G/4%A91Y!
M #G)+B_X_8Y7%,9GM?[:2!4VJ9Q8*EI5 C09]50=>,DB=$.)RN$\2\2HOO5"
M>Z\MUV$7.P+!R:+<,E;7$T,% 7?WM)A-ES-P(A686U2_.*Q"2FY9=6Q<\SNE
M*7$4>TP5?&1UP2-XN.BDSVIA8X4^C@=Q7HV-N&97,VL=TY@)C8MD1<4QL3+$
MJT!O<X[+HDSA3YR 5'W-05#=R]5N\(8*XLY-YS,%]E]G:4:()FCQORA3G [<
MD)I&RP\MMS$WZ5:E/8A<)RX17"RFQ/%8^1]>P1"66]391 >+UN=($Q@S[_V#
MWW^NGRJS.4FP:G&IH&)&R&&E,!9'.Q]OL,6/X'/S\5E9S:I3V/Y:^Q]/[MY9
M=>$@$2JUN?U)MH/)PV?UTU+1CJ90#EH!N$$$#[/3%_H!SE<PN-EB?7T,;<7-
M=U<R'$Z>91O;B%&< &Z'))0<)!J)=S$<7!A>6<<1MK2G@P)[TQ:NQ]897.-T
MK0Q9M6IHE9C!F&+H518R+QK2D8O:8 L/!];@Y'[G>D(FF/3%&]G3T^$6'/S:
M]SGV[:9G[J86W;UI61.7":P5':;R1?II,1F)#H:MD2&!@6B5-*:&"E[0_89=
MEZ>FD\23T::P40$!UAV739F:BLAEF5T0B"<?-@Y6:+R, S6&9*[LXK:#J:L:
M:-U/W,R+9K8[JQ@.3(=@*% W.,:>AZHTFX3!5:\3.9O\MIQP")X:X!@^PNEZ
M2QE@6P#1BY)(T1S;3:\>)+OT4E_GZFG%T@G6@"#/-^&/\,)71(*0"&Z3&# J
M<'[[?+/1V74JEE>5 XK,".2%]?$)/)?E!D?=XQ1H0P+\B+Q%Q609EI>6;KHL
M$DIL/8USJLG&3R(,2TM^*UN'4^?$.Y<=M5$BU\PZFD:J7)?QJ<5QY_P6U ?:
MR%HT=*6:3A:"9S1L$).J.?=E=B)15+0L_^8W2<DOX\NH&::ELZ@RG>";L94P
MFE2<EESM['Q@HT8K].KSEF*"QEBZXB.P;61<,(Y'[!E?:7[FT;?\S#5=F>&@
MQ#ASEVB5;\ /;.MB+*/L)#R-)FHM/8K$\5ARHR49=I@*<[Z*&\M3W+M"!C$W
MB0OK:M3+83!WWI1A9ZXUED(=!I@(*C91),W,CY/N8[S!+\'R+MPH O40+ZF8
MH*JC404+;_K'>J0ZY_4XCFER"S&8'=^BE4R>6Z_-48DZ5WV=DK6.(KVT[H^I
MWT90+AQ.O+'6E8@5P=!<,&J:G0_,54:,Y4[A1D&?@?^B 3=G=YEQ:!J-U3N9
M1VY*Z)0;ECTUYI?N3'.M9L*VFE;'*-$T4:K2Y/Q5FMA_2:*2XJ]4E<(0</Q'
M@K09^^\*1U+#-]O<#' Z6P(9)&=Y-F/0W2:;YJV8OGEY7M15R;>-M7A9NZPY
M&LRM6JGX 6?9?[)Z4LG4T>I+,2:H!YEUA@R?-51IN0 /?-GJY!U*3V$(B9O8
MO3)<^VIXX6M*\_G.N!E-D_6<,@7?9TVEB2@/KJ#3+X!<6?.-.)DJ+Y1$36@4
M59M7)9M;#>S01%S_ G([W=_?QZW-*\*@$#!W@B">I+YGIV3+H>ZHX43S6%W3
MB<J6W,6&Z/#=<V.B<- 9#-EVP;N[WY9K&L/Y<D'9C2\Z=<)U6%!UO5@=NQJ.
M_Z?C'-<;I&!.C8L%J1&%=<#W8LYT6=/A6GZ)'(@/N&:!**KUK[:(1L,!>7W;
M25'\]IMI6# =OYWQ(51(5M>PT1GU.]$\):39OBE.U$6XR"ZY),Q"9C3!4<@G
MY]EGJ@RV#H WS;L2EK0+C,YOD8<A\L%E9"(PR?<J8_RY;'+.9*G&@K-Y R'J
MJ [^G127U+HMM4&Z"XND>GLJK=A-ZSW[]$[!Q+8T,.1S;ST(&HJK2\XV<,R9
MPCBE:9J74DK08U>4\>!4M@ENI4X64T-.;$#TXMVAS)LZB^CM&5.&JK:Y=D#G
M*& !MW%8T<H$8V.ZG"5N?72:G!937#,J>"P$4)N9%VZ^0S*IR3UQ9,N2<!?G
MH.3<:.&<X_.7#EB/,JQ]K,Y6D>B=5CM2W1_<*SS=4:=\T (%9PZ9&"78]!.O
M*$.B%UJD'Y\R)?EC/?]/>Q_V<"@;+>=%5==+X(AWZ"(78^FOY^:=1])9>QYN
M>X2,@_;.B"VD[!*6C[;6=+:D-G;9>YI\+L:?1QE#  ;'+I_9DN4]<P9U.(@R
M&^FQ.K<EHQ1]L/D!&:#-4[,C,V2<S*U%C\"*YWKR.<\7(J@G @;!6*O=><TO
M2%^,>7UZ<Q_=GL[WYOOV^KR^;)9C:$ZA84Y&")5.2VN.=EJX%3=-;V-O](BD
M;"A=44O0VNE$%%=BY]40L)EXPYY![:.<GBX++.HK*;&EP[4F8.LH-"UR#D=\
M*0;=]0JXQFC-\,!?Z8A>VR.*F,2N'KG8(!OJ.*"];<4FD>R&0[FKPP1$><H]
MQSO6%E.ECH&N=54B<K,:3(X:2Q0<+,L-_;M8+CQZ9BB/G)#P<'"%F+ >L(\S
MF&YZWG^&\J3Y?!<C7;V%F[>JBK,I8N$[$+E18],IC,>_D1ZP?I7'2Q*K>4OO
MQ(>JU#EB^TLZGSR5\A$O9%F#.GZ)>%D,E>#YFF]?';WH#%H-@]L&SJ)G[IRV
MR1BH#5F#HB^S&Y9C99>Q!H*8/XT4S\XSD#;4G^BXJ(V>CIW_ER:_506VI'%!
M)_FX)5=0>"80AE$(BPPM<4G"$B09%WF(_!=.$[/"R8;*4ZY[77BVVZ'LLNP4
M8@T'FHXSOH:V4"WJPE8^HJBO3=N@[KR+SD*%3$#?N8NMXKLQ83EVZA*.KD&D
MF,!R&Q>RIX+<?' %^(L_)1?1'V,X+6G@&B2*^'F"BJM.7B%@ZK_PD? VO_S
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M Y*'"2:%VT@NS>4\=\+8-CUS[CHC*2+#)^)3*J(C*;R /<^-"'I4N9]#*=X
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M5,)NN:N(:!;2*D(I1D/K24(.',14W=>$05I!TEM8:-249V<CS2&=>8#,TWK
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M/S@*05I008X5PL2;(>@P(+ZZIZ>#R\X1B-&?'^T]HL^7(.759\'G<T0GZ/Y
MC?2UK(J_>0PT<-JY''1?J7]L!+2/%<0RT^FP?R#_.%83__3#(R#HX;'YX3?9
M"F_64)QZT'W_I?X>_NA;,ZDM6/0>4[73*PZBW'$+WN( ,0#+"P3M.9X6&Y6!
MB[Q@:Y[@_NX>'4V;N!^K+^^6<'UQ2997__*B3T8:T8>&C@L9:V1KA^^ZJ,<
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M.(X\97UG0XCTS9/#B^./\.6[X=GIP?\ 4$L#!!0    ( *6".E9ALN1UC D
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M6NW:7?;!H53 QF(I6T>H)^"7$L$?CS_Y!-_,HH:[].LP'KK?E/\/4$L#!!0
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M&DH7P49*W3!=I*D+3,K'B-HC.;12+:^N=A>.%K%,9,KUC)Q.2)47E*N +Y$
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M@UB[3!7435-R]J4@MU%9@50FST-WJUG_6I)HFB=LPD!7'#43G*XA@,#5RJ$
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MN-1;YN].9+MH^M<7])[_ %!+ P04    " "E@CI689@%4[D$  !N*@  %0
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M'@  $               @ &]PP  9#0S,C@R-F1E>#4Q+FAT;5!+ 0(4 Q0
M   ( *6".E:K<7.;?PH   4@   1              "  7?-  !D-#,R.#(V
M9&5X.3DQ+FAT;5!+ 0(4 Q0    ( *6".E9A'8R'"PL  .(@   1
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64$L%!@     )  D .0(  $KR      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
